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ABSTRACT 
Selectively reducing the excitability of specific neurons will (1) allow for the creation of 
animal models of certain human neurological disorders and (2) provide insight into the 
roles of specific sets of neurons, both in the local circuit and in the behavior of the intact 
organism.  This work focuses on a combined genetic and pharmacological approach to 
silence neurons electrically.  We express invertebrate ivermectin (IVM)-sensitive chloride 
channels (Caenorhabditis elegans GluCl α and β) in vertebrate neurons first in vitro using 
viral and tranfection techniques, and then finally in vivo using genetic techniques, to 
produce inhibition via a Cl- conductance when activated with IVM.  We have considerably 
engineered these two genes by (1) re-coding the genes such that vertebrate-preferred 
codons are used throughout the sequences, (2) incorporating fluorescent tags within the 
proteins, and (3) finding a mutation to remove the undesirable glutamate sensitivity of the 
channel while retaining IVM efficacy.  Expression of this new channel does not affect the 
normal spike activity of the target cell, yet the experimentor can effectively “shut-off” the 
cell with concentrations of as low as 5 nM IVM.  Chapter 1 provides a broad overview of 
the many “selective silencing” approaches that experimenters have tried. In Chapter 2, the 
author describes the basic “GluCl/IVM” technique and initial experiments in cultured 
hippocampal neurons. Chapter 3 refines the technique by describing the strategy and 
mutation that allowed great reduction in the native glutamate response while maintaining 
the IVM response.  Chapter 4 develops the final engineering of the channel: recoding the 
sequence for optimal expression and the introduction of fluorescent tags for identification.   
Finally, Chapters 5 and 6 discuss the successes and failures of in vivo work with what we 
now call the “GluCl/IVM method.” 
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C h a p t e r  1  
Introduction to Selective Silencing 
For example, it would be useful to be able to inactivate, preferably 
reversibly, a single type of neuron in a single area of the 
brain…Molecular biology is advancing so rapidly that it will soon 
have a massive impact on all aspects of neurobiology. 
Francis Crick wrote the above sentences while musing on new approaches required to 
“unscramble” the complicated systems we call brains (Crick, 1988; Wulff and Wisden, 
2005).  Simple invertebrate nervous systems have small networks of neurons that 
sometimes have only one or two cells of each type, lending them to exploration by current 
hyperpolarization.  Such silencing can reveal how specific components of neural circuits 
influence network properties or even contribute to animal behavior (Greenspan, 2004).  
These are not the systems that Crick was discussing.  Unfortunately, applying this approach 
for the study of complex brains found in vertebrate nervous systems is challenging, for two 
reasons: (1) there are often many cells of a given type, and (2) neuronal targets can be 
spatially dispersed populations (e.g. interneurons, Purkinje cells, or dopaminergic neurons 
in striatum.  There are countless examples that will only expand as more unique molecular 
signatures are identified.) 
For vertebrates, a cell-type-specific, reversible method for delicate analysis of circuitry that 
is able to work on the signaling timescale of the brain (milliseconds to seconds) does not 
yet exist (Steele et al., 1998; Miesenbock, 2004; Callaway, 2005; Wulff and Wisden, 
2005).  For the most part, experimenters have focused on either strictly genetic or strictly 
pharmacological techniques.  Unfortunately, genetics alone cannot induce new protein 
expression on the timescale of brain activity, and pharmacology alone often lacks 
specificity.  Rarely do naturally expressed receptors or ion channels provide unique drug 
targets of the experimenter’s choice.  The logical extension is to combine genetics and 
pharmacology, and a variety of approaches have been proposed and explored at different 
levels.  This thesis reports on the exploration of one of these approaches, called the 
  
2
“GluCl/IVM method.”  However, before a careful explanation of this technique we will 
first review the “Selective Silencing” field.    
Drosophila selective silencing 
Many genes are used for reducing the excitability of neurons in a variety of preparations, 
both in vitro and in vivo (Table 1-1).  Clearly, the largest successes are in the fruit fly 
Drosophila.  In the Drosophila nervous system, the light chain of tetanus toxin (TeNT) was 
used to interrupt synaptic transmission and observe behavioral defects (Sweeney et al., 
1995; Keller et al., 2002; Martin et al., 2002).  TeNT cleaves the vesicle-associated 
membrane protein 2 (VAMP2 or synaptobrevin), which is required for Ca2+-regulated 
synaptic vesicle exocytosis.  Thus, expression of TeNT will block synaptic transmission 
without directly killing the cell. The neuronal substrate of the olfactory escape response 
was studied in this fashion (Sweeney et al., 1995).  Overexpression of K+ channels, which 
clamps the neuron at its resting membrane potential, also works quite well in Drosophila 
(Baines et al., 2001; White et al., 2001a; White et al., 2001b).  For example, this technique 
was used to show a disruption in circadian behavior of the animal due to electrical silencing 
of circadian pacemaker neurons, while leaving the light-dark driven molecular clock intact 
(Nitabach et al., 2002).  Also in Drosophila, local expression of temperature-sensitive 
dynamin can transiently block synaptic transmission in minutes (Kitamoto, 2001, 2002).   
The shibire gene encodes a dynamin GTPase that is essential for synaptic vesicle recycling 
and maintaining the release pool of synaptic vesicles.  Shibirets1 has a mutation making the 
protein inactive at temperatures >29 C.  Rapidly shifting temperatures causes synaptic 
transmission to terminate at 32 C and reactivate at 25 C.  The importance of mushroom 
bodies and dorsal paired medial neurons in Drosophila memory formation was 
demonstrated with this technique (Dubnau et al., 2001a; McGuire et al., 2001).   
Unfortunately, the move to vertebrate systems has not been so straightforward as one might 
have predicted.  Some of these Drosophila techniques have been applied in vertebrates and 
have met with limited success.  The following text focuses on excitability modulation 
approaches in vertebrate systems. 
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In vitro applications 
Gene Target cells Reference 
aKV1.2 Aplysia neurons (Kaang et al., 1992) 
aKV5.1 Aplysia neurons (Zhao et al., 1994) 
GFP-KV1.4 Skeletal myoballs (Falk et al., 2001) 
dKV1.1 Cardiac myocytes (Johns et al., 1995) 
rKir3.x (GIRKs) Hippocampal neurons (Ehrengruber et al., 1997) 
GFP-Kir2.1 SCG Neurons, hair cells (Johns et al., 1999) 
HERG Cardiac myocytes (Hoppe et al., 2001) 
EKO Aplysia neurons (White et al., 2001b) 
rKir1.1 Hippocampal neurons (Nadeau et al., 2000) 
hGABACR Hippocampal neurons (Cheng et al., 2001) 
ceGluCl Mammalian neurons (Slimko et al., 2002) 
TeTxLC Aplysia neurons (Mochida et al., 1990) 
DroAlstR Ferret cortical neurons (Lechner et al., 2002) 
RASSL COS-7 cells (Coward et al., 1998) 
In vivo applications 
Gene Target tissues Reference 
xKV1.1,xKV1.2 Xenopus embryonic neurons (Jones and Ribera, 1994) 
Drosophila embryonic neurons (White et al., 2001b) 
Drosophila larval muscles (White et al., 2001b) 
EKO 
Drosophila photoreceptors (White et al., 2001b) 
ceKV3 C. elegans motor neurons (Zhao and Nonet, 2000) 
rKV1.1,rKV1.2 C. elegans sensory neurons (Peckol et al., 1999) 
Drosophila photoreceptors (Hiesinger et al., 1999) 
Drosophila embryonic neurons (Sweeney et al., 1995) 
Drosophila sensory neurons (Martin et al., 1998) 
Drosophila ventral lateral neurons (Kaneko et al., 2000) 
Drosophila Ddc+ neurons (Blanchardon et al., 2001) 
Drosophila giant fiber neurons (Allen et al., 1999) 
Drosophila pacemaker neurons (Nitabach et al., 2002) 
Mouse cerebelllar granuale cells (Yamamoto et al., 2003) 
TeTxLC 
Mouse olfactory neurons (Yu et al., 2004) 
Drosophila motor neurons (Baines et al., 2001) 
Drosophila larval muscles (Paradis et al., 2001) 
GFP-Kir2.1 
Drosophila photoreceptors (Hardie et al., 2001) 
Drosophila photoreceptors (Kitamoto, 2001) 
Drosophila peptidergic neurons (Waddell et al., 2000) 
Drosophila MB neurons (Dubnau et al., 2001b) 
Shits1 
Drosophila cholinergic neurons (Kitamoto, 2001) 
Drosophila muscles (Zagotta et al., 1989) dKV1.1 
Drosophila neurons (Zhao et al., 1995) 
aKV1.1 Mouse CNS (Sutherland et al., 1999) 
rSK3 Mouse myotubes (Bond et al., 2000) 
Dunc-18 Drosophila Neurons (Wu et al., 1998) 
Syt I Drosophila neuromuscular junction (Marek and Davis, 2002) 
ceGluCl Zebrafish retina This work 
α-bungarotoxin Zebrafish neurons (Ibanez-Tallon et al., 2004) 
RASSL Mouse heart (Redfern et al., 1999) 
Table 1-1: Various genes that have been employed to suppress the excitability of 
neurons.  While such strategies have been successful in Drosophila, experiments in 
mammalian systems have been more challenging.  Adapted and expanded from White et al, 
2001. © (2001) Elsevier Science Ltd. 
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Genetic ablation and inactivation 
Careful analysis of deficits experienced by humans with damaged or missing brain parts 
has led to giant leaps in the understand of the vertebrate nervous system (Morris, 1999; 
Damasio, 2000; Goodale and Milner, 2003).  Much of systems neuroscience is based on 
ablating brain regions or nuclei of a variety of animals (Izquierdo and Medina, 1998).  
While ablation of a brain region does not necessarily provide insight into its function, it 
does show its relationship to other regions, suggesting systems but not local mechanisms.  
Cell-type-specific ablation studies have been undertaken to address local mechanisms.  
This can be done a number of ways.  For example, by using transgenic techniques to 
express toxins that directly kill the cell (Sato and Tanigawa, 2005) or by expressing 
proteins that bind an injected agent that then kills the cell (Kobayashi et al., 1995).  
Unfortunately, ablation, whether regional, cellular, or genetic, often causes compensations 
or adaptation, confusing the interpretation of these experiments (Greenspan, 2001).  These 
unexpected compensations are interesting and have been studied.  For example, the 
selective ablation of Golgi cells in the cerebellum was originally intended to study the 
function of these cells, but instead resulted in documenting compensatory mechanisms 
(Watanabe et al., 1998; Hirano et al., 2002).  While perhaps not so helpful for the original 
purpose of studying the function of the cells destroyed, this provided an excellent example 
of long-term plasticity and genetic resilience of the nervous system.  However, to achieve 
the ideal of a technique well-suited to circuit modulation and behavioral studies, the 
interference must be reversible, ideally on timescales from milliseconds to several minutes.  
Clearly, ablation does not fit this requirement. 
Several genetic-only approaches to inactivation have been based on expression of K+ 
channels. Cultured sympathetic neurons have been silenced using viral infection of the 
Kir2.1 inwardly-rectifying potassium channel gene (Johns et al., 1999).  DOX-regulation of 
this gene selectively expressed in olfactory sensory neurons in vivo was used to effectively 
silence them and thus demonstrate the role of activity in constructing a sensory map (Yu et 
al., 2004).  Some success derived from transgenically overexpressing the Kir6.2 channel in 
forebrain neurons, resulting in a strong loss of spontaneous activity from neocortical and 
hippocampal neurons, although these mice were not inducible (Heron-Milhavet et al., 
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2004).  Not all potassium channels result in predictable changes in cell excitability, 
however.  For example, ROMK1 caused apoptosis and is probably not suitable for in vivo 
work (Nadeau et al., 2000), and Shaker-type K+ channels dysregulated native potassium 
gene expression (Sutherland et al., 1999). 
The light chain of tetanus toxin (TeNT) approach from Drosophila was used to temporarily 
inactivate cerebellar granule cells in mice (Yamamoto et al., 2003).  Cell-type-specificity 
and reversibility is achieved by using the tetracycline-controlled reverse (rtTA) activator 
system.  The rtTA gene is expressed only in cerebellar granule cells driven by the GABAA 
receptor α6 subunit promoter (Bahn et al., 1997).  The rtTA protein is an inactive 
transcription factor unless it binds doxycycline (DOX); rtTA-DOX then translocates to a 
tetracycline-responsive element (TRE) in the promoter of a TeNT minigene and drives 
expression of the toxin (Figure 1-1a).  The TRE-TeNT gene is inactive unless DOX is 
given in the animal’s drinking water.  High levels of TeNT were detected in cerebellar 
granule cells after five days of DOX treatment and these levels were maintained as long as 
DOX was given to the animals.  Unfortunately, it took nearly two weeks for the levels of 
TeNT to decay once DOX was withdrawn from the animal’s water supply.  During DOX 
treatment, a behavioral phenotype consistent with cerebellar disruption was observed, 
namely a marked decrease in performance on the rotarod, a standard test for motor 
coordination.  Two weeks after DOX removal, animals recovered their motor skills (Figure 
1-1b,c,d) (Yamamoto et al., 2003). The slow kinetics of gene activation and deactivation 
are partly due to the pharmacokinetics of DOX; however an intrinsic limit on the speed of 
the deactivation and reactivation is the need for first RNA transcription and then protein 
synthesis followed by protein degradation.  Hence, the technique is limited to exploring 
how chronic inactivation of activity over days to week effects behavior and network 
properties.  A similar approach has been used to study the formation and maintenance of 
sensory maps in the mouse olfactory bulb (Yu et al., 2004); however, in this work no 
behavioral modulation was reported. 
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FIGURE 1-1 
 
Figure 1-1: Inhibition of synaptic transmission of cerebellar granule cells by 
doxycycline (DOX)-dependant reversible expression of tetanus toxin (TeNT).  A, in the 
absence of DOX, the tetracycline-controlled reverse activator (rtTA) transcription factor 
does not bind and no protein is produced.  In the presence of DOX, rtTA binds the 
tetracycline response element (TRE) and activates transcription of the toxin, which 
subsequently cleaves VAMP2 and stops with synaptic transmission.  B, In the absence of 
DOX, all mice genotypes have similar ability on the rotorod. C, in the presence of DOX for 
13 days, only mice carrying both the rtTA gene and the TRE cassette lose the ability to 
perform on the rotorod.  D, three weeks after the removal of DOX, these mice recover their 
ability to perform.  All panels adapted from Yamamoto et al, 2003. © (2003) the Society 
for Neuroscience.  
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Pharmacological manipulations of brain activity 
Pharmacological disruptions of brain circuits are attractive because of their acute 
reversibility.  GABA agonists, glutamate receptor antagonists, and short-acting anesthetics 
have been used to locally silence brain regions (Hupe et al., 1999; Riedel et al., 1999).  The 
nervous system is unable to engage compensatory mechanisms because of the acute nature 
of these approaches.  Unfortunately, these approaches are generally constrained to operate 
only on locally defined groups of neurons, as their target receptors are generally widely 
expressed.  While these techniques have provided invaluable information to systems 
neuroscience, the field is still wanting of a higher precision technique. 
The “Selective, Reversible, and Rapid” ideal of Selective Silencing 
The genetic techniques in vertebrates explored to date have been selective, and in some 
cases reversible; however they are far from rapid.  On the other hand, pharmacological 
techniques have been rapid and reversible, but far from specific.  The field appears to have 
been constrained to “pick two” elements of the ideal, and this has led a number of workers 
to attempt to develop more refined techniques.  The natural extension of the genetic-only 
and pharmacological-only techniques is to try to combine the two and there have been a 
number of ambitious attempts to do exactly that. 
Ligand-activated K+ conductances 
As discussed previously, the static clamping of neuronal activity using inward-rectifying 
K+ channels has been demonstrated.  However, for dissecting the roles of cell types in fast 
circuit signaling, a ligand-controlled K+ channel is needed to induce inhibition transiently.  
While there are no known directly ligand-gated K+ channels, many neurotransmitters 
modulate cellular K+ conductance through G-protein coupled receptors (GPCRs).   
Conklin and colleagues engineered GPCRs to eliminate sensitivity to endogenous ligands 
but retain sensitivity to synthetics ligands in a technique they call RASSL (receptor 
activated solely by a synthetic ligand) (Redfern et al., 1999; Scearce-Levie et al., 2001).  
Many natural GPCRs could be platforms for RASSL design, and there are a variety of 
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synthetic agonists and antagonists available.  The original RASSL strategy used a mutated 
κ opioid receptor to activate Gi (Coward et al., 1998), thus activating G protein-activated 
inward rectifier (GIRK) channels.  This RASSL, termed Ro1, is insensitive to 21 natural 
opioid peptides but is activated by the drugs spiradoline and bremazocine.  When 
transgenic mice expressing Ro1 in the heart were given the agonist spiradoline, their heart 
rates decreased by as much as 80% (Redfern et al., 1999).  In a further example, Claeysen 
and colleagues made a RASSL of the 5-HT4  receptor (Claeysen et al., 2003).  The 5-HT4-
RASSL stimulates, via Gs, cAMP formation in response to the synthetic ligand GR 113808 
but not to 5-HT.  The difficulty with the technique is that the native receptors also respond 
to the synthetic ligands, so any mouse in which this is attempted would have to be done on 
a native receptor knockout to achieve interpretable results.  A completely artificial RASSL-
ligand system is desired. 
Using a similar strategy, Lechner and colleagues exploited the Drosophila allatostatin 
GPCR (Lechner et al., 2002) (Figure 1-2).  The receptor is unresponsive to mammalian 
peptide ligands such as somatostatin, galanin, or enkephalins, and the Drosophila 
allatostatin peptide does not activate any known mammalian receptors.  Te receptor opens 
GIRK channels via coupling to Gi/o.  Neonatal ferret neocortex slices were cotransfected 
with plasmids encoding the Drosophila allatostatin receptor and mammalian GIRK channel 
subunits 1 and 2.  Adding allatostatin peptide produced hyperpolarization within minutes 
that reversed upon removal of the peptide.  The hyperpolarization combined with the 
additional resting conductance markedly increased the current required to elicit action 
potentials.  When used in a cell-specific expression system, this method offers significant 
promise.  However, any target neuron must have sufficient GIRK channels either naturally 
or transgenically expressed, and because allatostatin is a peptide it will not cross the blood 
brain barrier and must by directly infused into the target brain region.  The requirement to 
express GIRK channels may have non-specific effects. 
Channel-specific toxins 
A variety of ion channel types are blocked by channel-specific toxins.  Ibanez-Tallon and 
colleagues expressed peptide toxins selective for specific ion channels on the neuronal  
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FIGURE 1-2 
 
Figure 1-2: Silencing of cortical neurons with the AlstR/AL receptor/ligand system. 
A1, The spike threshold of a representative AlstR-transfected neuron was determined by a 
series of depolarizing current pulses (Istim, 1 sec duration; left panel) before addition of 
allatostatin to the bath (gradually shaded bar). In this example, the spike threshold was 
found to be at +14 pA. Before and after the onset of perfusion with 1 nM AL, input 
resistance was monitored by hyperpolarizing current pulses at 5 sec intervals (middle 
panel). Input resistance and resting membrane potential decreased within minutes of AL 
application. The amount of current necessary to elicit an action potential in the presence of 
AL (+118 pA) was greatly increased with respect to the initial values (right panel). A2, The 
effects of AL were reversible over the course of several minutes by washing out AL with 
normal ACSF. Input resistance, membrane potential (left panel), and spike threshold (right 
panel) returned to approximately initial values after a perfusion time approximately 
equivalent to the time required for the exchange of one bath volume (see Results). B, Input 
resistance, membrane potential, and spike threshold of control neurons were unaffected by 
application of AL.  All panels reproduced from Lechner et al, 2002 © (2002) The Society 
for Neuroscience.  
  
10
surface by fusing them to a glycosylphosphatidylinositol anchor and linker (Ibanez-Tallon 
et al., 2004).  Several toxin-receptor pairs are considered, including α-bungrotoxin and 
nicotinic receptors, μO-conotoxin and Na+ channels, and ω-conotoxin and Ca+ channels.  
In cells expressing the receptor associated with the toxin, the toxin binds and blocks the 
receptor.  This technique is unique in that it targets input from specific receptors in a 
neuron, rather than targeting the excitability of the neuron itself.  The blockage is not 
inducible other than with transcriptional control; however, it may be possible to cage the 
membrane-tethered toxin so that it could be stimulus-activated. 
Selective, reversible, and rapid excitation of neurons 
While the above techniques have been developed to suppress neuronal activity, Zemelmann 
and colleagues have developed a cell specific excitation approach.  In the Drosophila 
retina, light causes depolarization rather than the hyperpolarization found in vertebrates.  
When the Drosophila phototransduction cascade (arrestin, rhodopsin and Gqα, together 
termed chARGe) is expressed in cultured hippocampal neurons, light triggers an excitatory 
response (Zemelman et al., 2002).  The rhodopsin receptor couples to endogenous non-
selective cation channels of the transient receptor family (TRP) through Gqα.  Arrestin is 
necessary to inactivate and recycle the rhodopsin.  Upon opening, the TRP channels 
depolarize the cell.  Hippocampal neurons transfected with the chARGe phototransduction 
components showed no change in electrical properties while in the dark.  Illumination of 
the cultures elicited action potential trains, provided that the chromophore retinal was 
supplemented (to generate rhodopsin from opsin).  However, there was poor temporal 
coupling between stimulus and response; neurons continued firing for minutes after light 
removal.  Expressing the three charge components in a targeted neuron in vivo could be 
demanding. 
Another approach uses the vanilloid receptor TRPV1, which is gated by capsaicin or the 
receptor TRPM8 which is gated by methanol (Zemelman et al., 2003).  Both receptors are 
homotetrameric non-selective cation channels.  In mammals, these receptors are expressed 
in peripheral neurons but not in the CNS.  Cultured hippocampal neurons transfected with 
either TRP receptor were slightly depolarized even with no ligand, suggesting a small leak 
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conductance through the channel.  Strong spiking in neurons expressing the cognate 
receptors was evoked upon the addition of ligand (Figure 1-3).  Photorelease of caged 
capsaicin increased the temporal and spatial precision: a 1 s UV-light pulse evoked an 
action potential volley within seconds.  Repeated photostimulation gave reproducible 
responses without attenuation.  The choice of activation trigger, light or ligand, gives 
flexibility.  Delivery of the required ligands in vivo at sufficient concentrations will be 
challenging. 
Gene delivery with viruses 
Clearly, all the techniques discussed above rely on the ability to selectively express one or 
more genes in a target set of neurons.  The experimental goals set constraints on the ideal 
vector for transgene delivery.  The target cells must first be susceptible to the vector under 
consideration with appropriate efficacy. Once the genetic material is inside, the cell must 
have the ability to express the transgene.  Unfortunately, virologists have not been able to 
identify a “universal vector” that is capable of infecting any cell type at high efficiency 
(Callaway, 2005).  Many different vectors have been used throughout the literature, 
including adeno-associated virus (AAV) (Davidson et al., 2000; Kaspar et al., 2002; 
Rabinowitz et al., 2002; Rabinowitz et al., 2004), lentiviruses (Naldini et al., 1996; Blomer 
et al., 1997), Sindbis viruses (Gwag et al., 1998), and herpes simplex virus (HSV) (Sandler 
et al., 2002).  All of these vectors can deliver DNA (or RNA) efficiently to non-dividing 
adult neurons within 0.5-1.0 mm of an injection site.  The vectors are replication 
incompetent and hence there is no further spread or toxicity. However, each of these 
viruses also has tropism for different neuronal subtypes, and the experimenter must first 
empirically determine if the target cell of interest is susceptible to infection by a given 
vector.  The inherent tropism of these vectors may at first seem like a severe limitation.  
However, clever experimenters used it to advantage: it becomes part of the targeting 
scheme (Watson et al., 2002). Viruses were also engineered to have tropism for a particular 
cell type or to expand the range cell types that can be infected (Bartlett et al., 1999; Grandi 
et al., 2004). 
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FIGURE 1-3 
 
Figure 1-3: Pharmacological stimulation of genetically designated target neurons. The 
membrane potentials of hippocampal neurons expressing TRPV1 (Top), TRPM8 (Middle), 
and P2X2 (Bottom) were recorded in whole-cell current-clamp mode. All neurons were 
challenged sequentially with 50 nM capsaicin (Left), 100 µM menthol (Center), and 50 µM 
ATP (Right); approximate periods of agonist application are indicated by horizontal bars. 
Only cognate matches between ionotropic receptor and agonist (shaded entries in the 
diagonal) elicit action potentials. Increased baseline noise of the TRPV1-expressing neuron 
after the application of capsaicin (Top, Center and Right) is caused by residual capsaicin in 
the perfusion system.  Reproduced from Zemelman et al, 2003 © (2003) National 
Academy of Scientists.  
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Capacity is the major limitation of viral vectors.  Often, cell-type-specific promoters are too 
large to fit within the viral genome.  AAV and lentivirus can package genetic sequences up 
to ~5 kb and ~8kb, respectively (Samulski, 2000; Kafri, 2001), whereas the 152 Kb 
genome of HSV could potentially accept much larger genetic sequences.  High-titer HSV 
amplicons incorporating bacterial artificial chromosomes (BACs) ~130 Kb in size have 
been reported (Wade-Martins et al., 2003; Xing et al., 2004).  Cell-type-specificity is likely 
to be enhanced by further developments in these types of vectors.  
Transgenic approaches to gene targeting 
By far the most common approach to achieve cell-type-specific targeting is to use a cell-
type-specific promoter.  For example, Purkinje cell protein 2 (Pcp2, also known as L7) is 
restricted to cerebellar Purkinje cells and retinal bipolar cells (Oberdick et al., 1990).  The 
2.9 Kb DNA sequence upstream from this gene was used to drive expression in these cell 
types (Zhang et al., 2001).  Many other examples of cell-type-specific promoters are useful 
in generating mouse lines with targeting expression, but there are also many unsuccessful 
attempts.  Generally, the probability of success and degree of specificity are greatly 
increased as longer stretches of DNA sequence are used, presumably because larger 
portions of the proper regulatory sequences are included.  BAC transgenics, which can use 
more than 200 Kb of DNA, have been very successful (Heintz, 2001).  The challenge arises 
because the mechanisms and sequences that regulate gene expression are poorly 
understood. 
In addition to traditional transgenics and BAC transgenics, knock-in strategies allow for the 
expression of exogenous genetic sequences in specific cell-types, without the need to 
identify specific promoter elements.  For example, given a silencing gene under 
consideration, one could knock that gene directly into the locus of another gene that is 
expressed exclusively in the target neurons, either by knocking out the target gene (and 
thereby using heterozygous animals) (Tamamaki et al., 2003) or by knocking in an internal 
ribosome entry site (IRES)-silencing gene cassette into the 3’ untranslated region of the 
target gene (Lindeberg et al., 2004).  In a more sophisticated approach, Yu and colleagues 
knocked in an IRES-tetracycline transcriptional activator cassette in the 3’ untranslated 
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region of the OMP gene, and then crossed this mouse with a transgenic carrying a 
tetracycline response element (TRE)-silencing gene cassette (Yu et al., 2004).  This work 
demonstrated the utility of combining traditional transgenics with knockins. 
The use of cell-type-specific promoters with viral vectors is important, because it may not 
be desirable to modulate all neurons in a given geometric area (i.e, at the injection site).  
Instead, a given experiment is more likely to require affecting only a given cell type in that 
area.  Hence, the vector must contain a cell-type-specific promoter to restrict the 
expression. From above, the major limitation on viral vectors is their cloning capacity.  
Hence, a considerable amount of trial-and-error work must be done to attempt to identify 
the minimum sequence required to achieve cell-type-specificity.  Often, no such minimum 
sequence can be identified because there is no definitive method for localizing regulatory 
sequences, although this has been tried (Wasserman and Sandelin, 2004).   
Neurons can differ not only in the genes they express, but also in the distant structures to 
which they project their efferent axons.  It is possible to pseudotype a lentivirus with the 
envelope protein from rabies virus, enabling it to infect neurons efficiently through their 
axon terminals (Mazarakis et al., 2001; Wong et al., 2004).  HSV infects neurons through 
their axon terminals (Sandler et al., 2002).  Specific neurons can thus be targeted based 
upon their distant axonal projections. 
Directions for the future 
Unique subsets of neurons are defined by their location, their morphology, their specific 
molecular components, or a combination of all three elements.  Since the time of Cajal, 
brain anatomists have made great strides classifying cells via the first two elements.  As the 
approximately 15,000 genes expressed in the mammalian brain are characterized and 
mapped, neurons are likely to be increasingly identified by the genes they express. 
Researchers in brain genomics have been surprised at the wide expression of several genes 
studied to date, but there are many genes left to explore.  Tools that molecular biology can 
provide to help tease apart the function of these neuronal subsets and their roles in the local 
circuit and ultimately the organism’s behavior will be valuable. 
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Researchers have developed predictive descriptions of circuits through modeling efforts, 
especially for highly stereotypic structures like the cerebellum and hippocampus (Medina 
and Mauk, 2000; Whittington and Traub, 2003). The actual consequences of manipulating 
the activity of a particular cell need to be tested in comparison to the model prediction.  
Giving a drug to an animal so that particular neuronal types in these circuits could be 
temporarily silenced or excited would be an incisive methodological advance (Wulff and 
Wisden, 2005).  The field needs a spectrum of methods that can be tailored to particular 
applications, as each method is likely to have strengths and weaknesses.  Using genes from 
invertebrate biology is promising, as often these animals employ transmitters not used in 
vertebrate brains, allowing direct transplantation of signaling systems (Miesenbock, 2004).  
Transgenic techniques as well as viral expression techniques will be vital for neuronal 
modulation in mice and other animals (Callaway, 2005).  Bacterial artificial chromosomes 
(BACs) will allow the production of transgenic mice with a higher likelihood of resulting 
in a desired, consistent pattern of gene expression (Gong et al., 2003).  Surprisingly, despite 
years of effort by several researchers, there has been only one “silencing” mouse that has 
linked changes in the excitability properties of target neurons to behavior of the animal 
(Yamamoto et al., 2003).  The field is still open for unique approaches to selectively and 
reversibly inhibit or stimulate specific neuronal types in vertebrate systems. 
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C h a p t e r  2  
Selective electrical silencing of mammalian neurons in 
vitro using invertebrate ligand-gated chloride channels 
 
 
 
Text of this chapter is reproduced, with minor editing, from: 
 
Slimko EM, McKinney S, Anderson DJ, Davidson N, Lester HA. (2002) Selective 
electrical silencing of mammalian neurons in vitro using invertebrate ligand-gated 
chloride channels. J. Neurosci 22(17):7373-7379
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Abstract 
Selectively reducing the excitability of specific neurons will (1) allow for the creation of 
animal models of human neurological disorders and (2) provide insight into the global 
function of specific sets of neurons.  We focus on a combined genetic and 
pharmacological approach to silence neurons electrically. We express invertebrate 
ivermectin (IVM)-sensitive chloride channels (C. elegans GluCl α and β) with a Sindbis 
virus, then activate these channels with IVM to produce inhibition via a Cl- conductance.  
We constructed a three-cistron Sindbis virus that expresses the α and β subunits of GluCl 
along with the green fluorescent protein (EGFP) marker.  Expression of the C. elegans 
channel does not affect the normal spike activity or GABA/glutamate postsynaptic 
currents of cultured E18 hippocampal neurons.  At concentrations as low as 5 nM, IVM 
activates a Cl- current large enough to effectively silence infected neurons.  This 
conductance reverses in eight hours.  These low concentrations of IVM do not potentiate 
GABA responses.   Comparable results are observed with plasmid transfection of yellow 
fluorescent protein (EYFP) tagged GluCl α and cyan fluorescent protein (ECFP) tagged 
GluCl β.  The present study provides an in vitro model mimicking conditions that can be 
obtained in transgenic mice and in viral mediated gene therapy.  These experiments 
demonstrate the feasibility of using invertebrate ligand-activated Cl- channels as an 
approach to modulate excitability. 
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Introduction 
This paper focuses on an approach to understanding the role of individual neuronal cell 
types in development, information processing, and behavior.  Several investigators have 
suggested that such information can be obtained by employing gene transfer in vitro, or 
transgenic animals, to produce spatially and temporally controlled inactivation of specific 
neurons  (White et al., 2001a).  Recent studies report using transcriptional induction of 
various K+ channels (Johns et al., 1999; Falk et al., 2001), and this method silences 
Drosophila neurons or muscle in vivo (Paradis et al., 2001; White et al., 2001b; Nitabach 
et al., 2002), providing useful insights into the role of defined neuronal populations.  We 
previously studied the possibilities for neuronal silencing using expressed GIRK channels 
(Ehrengruber et al., 1997), weakly inward rectifying K+ channels (Nadeau et al., 2000), 
and neuron restrictive silencing factor (Nadeau and Lester, 2002).  However, there are 
indications that K+ channels may cause unwanted side effects, such as apoptosis due to 
sustained K+ efflux, in the cultured mammalian CNS neurons used to test this strategy 
(Nadeau et al., 2000). 
 The emerging genetic techniques seem to present some advantages over previous 
exclusively pharmacological strategies.  Target areas and nuclei have indeed been 
inactivated in vivo through focal application of a GABA agonist, muscimol (Jasnow and 
Huhman, 2001; Maren et al., 2001).  This procedure has been valuable in determining the 
role of the amygdala and hippocampus in fear conditioning (Helmstetter and Bellgowan, 
1994; Muller et al., 1997; Holt and Maren, 1999; Wilensky et al., 1999, 2000).  However, 
the muscimol strategy suffers from limitations, such as the inability to know exactly 
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which neurons were silenced, the inability to silence specific cell types in a given brain 
region, the inability to silence distributed but functionally related neuronal populations, 
and the irreproducible localization of focal injections.  Also, specific neuronal 
populations have been irreversibly ablated (Kobayashi et al., 1995; Sawada et al., 1998; 
Watanabe et al., 1998; Isles et al., 2001), but further insights could arise from a reversible 
technique. 
We suggest a strategy that combines the genetic and acute pharmacological 
manipulations.  Because GABA and glycine are the major inhibitory neurotransmitter in 
the brain, and because GABAA and glycine receptors inhibit activity by activating a Cl- 
conductance, we have explored the possibility of using ligand-activated Cl- channels as 
silencing genes.  The GluCl family of ligand-gated Cl- channels, found in several 
invertebrate phyla, is the target for various pesticides, anthelminthic, and antiparasitic 
drugs, including ivermectin (IVM) (Cully et al., 1994).  GluCl channels are part of the 
nicotinic receptor superfamily, characterized by four transmembrane segments and a 
large N-terminus, and are most similar to GABAA and glycine receptors.  Glutamate is 
the putative in vivo ligand for these channels.  No GluCl channels have yet been detected 
in mammals (Martin et al., 1998; Xue, 1998).    
The GluCl channels may represent a promising set of silencing genes.  We have 
used a recombinant Sindbis virus to express these channels in cultured neurons, then 
tested whether the expressed channels can be activated with high sensitivity and high 
selectivity by IVM.  Indeed we do find that that IVM at low nM concentrations induces a 
large Cl- conductance in some infected neurons, effectively clamping the membrane at a 
potential near the original resting potential.  As a result, neither current injection nor focal 
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application of excitatory transmitter elicits action potentials.  We also studied possible 
unwanted additional effects of either GluCl channel expression or IVM application, and 
found these potential side effects to be minimal or non-existent.  The inducible and 
reversible nature of this inactivation, which we term the GluCl / IVM method, represents 
a potential powerful new technique for use in probing the contributions of specific 
regions of the nervous system to the global function.  
Materials and Methods 
Viral Vectors and Preparation. Wild-type C. Elegans GluCl α and GluCl β genes (Cully 
et al., 1994) cloned into pBluescript II SK+ were a kind gift from Merck Research 
Laboratories (Whitehead, NJ), the Sindbis vector pSinRep5dsgEGFP was a kind gift 
from Drs. H. Nawa and M. Kawamura of Niigata University, Niigata, Japan.  The oligos 
pSG1: 5’-6CG ACG TCA TCT CTA CGG TGG TCC TAA ATA GTT TAA ACG CAT 
G –3’ and pSG2: 5'-6CG TTT AAA CTA TTT AGG ACC ACC GTA GAG ATG ACG 
TCG CAT G-3' were annealed and ligated into the SphI site of pSinRep5dsgEGFP, 
resulting in pSinRep5tsgEGFP.  GluCl α was then amplified by PCR with the primers 5'-
ATA GAT ACG CGT TCA ATA CTG CAT AAA T-3' and 5' TAG ATT CAC GTG 
AAA GCA TTC TCG ATC A 3' and cloned into the MluI and AatII sites of 
pSinRep5tsgEGFP, resulting in pSinRep5tsgGluClαEGFP.  GluCl β was then amplified 
by PCR with the primers: 5' AAT GCA GCA TGC ACT ACA CCT AGT TCA T 3' and 
5' ACC GGT GCA TGC TAT GAT GTT TGC AAA T 3' and cloned into the SphI site of 
pSinRep5tsgGluClαEGFP resulting in pSinRep5tsgGluClαβEGFP (Figure 2-1).  This 
plasmid was then used to generate recombinant Sindbis virus according to the  
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FIGURE 2-1 
 
 
Figure 2-1:  Modified pSinRep5 construct, pSinRep5tsgGluClαβEGFP, designed to 
express three genes with three subgemomic promoters: the GluCl α subunit, the GluCl β 
subunit, and the reporter EGFP.   The resulting Sindbis virus is vSinGluClαβEGFP.  
P 
SG P SG PSGGluCl α GluCl β EGFP PolyA
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manufacturer’s instructions.  Briefly, RNA was transcribed from this plasmid and the 
DB-26S helper plasmid using the Invitogen InvitroScript kit (Carlsbad, CA).  These two  
RNA species were transfected by electroporation into baby hamster kidney cells and 
incubated for 48 h.  The supernatant was collected and filtered at 0.2 μm, and the viral 
particles (termed vSinGluClαβEGFP) were concentrated by centrifugation at 35,000 rpm 
for 1 h. 
Neuronal Culture. Rat embryonic day 18 hippocampal neurons were prepared as 
described (Li et al., 1998).  Hippocampal cultures were then infected with 1 to 5 μl of the 
above virus stocks per 35 mm culture dish containing ~ 2 ml of media.  Neurons were 
infected after 12–16 days in culture, and recordings were made 24-48 h later.  For neuron 
transfection experiments, Lipofectamine 2000 from Invitrogen (Carlsbad, CA) was used 
in conjunction with Nupherin-neuron from Biomol Research Laboratories (Plymouth 
Meeting, PA) per manufacturer’s instructions.  Briefly, 5 μg DNA of each tagged subunit 
was incubated with 120 μg of Nupherin-neuron in 400 μl of Neurobasal medium without 
phenol red, while 10 μl of Lipofectamine 2000 was mixed in 400 μl Neurobasal.  After 
15 min, the two solutions were combined and incubated 45 min.  Neuronal cultures in 35 
mm culture dishes were incubated in the resulting 800 μl mixture for 5 min, spun in a 
swinging bucket centrifuge at 1000 rpm for 5 min, incubated for 4 h, and then the mixture 
was removed and replaced with the original 2 ml medium.  Recordings were made 24-48 
h later. 
 
Electrophysiology. The bath solution was (in mM): 110 NaCl, 5.4 KCl, 1.8 CaCl2, 0.8 
MgCl2, 10 HEPES, and 10 D-glucose, pH 7.4, osmolarity 230 mOsm. Patch pipettes were 
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filled with a solution containing (in mM): 100 K gluconate, 0.1 CaCl2, 1.1 EGTA, 5 
MgCl2, 10 HEPES, 3 ATP, 3 phosphocreatine, and 0.3 GTP, pH 7.2, 215 mOsm. Whole-
cell voltage clamp was maintained using an Axopatch-1D amplifier controlled by a 
personal computer running pCLAMP 8 software via a Digidata 1200 interface (Axon 
Instruments). Data were filtered at 2 kHz and digitized at 5 kHz.  Drugs were applied 
focally to single voltage- and current-clamped neurons using a Picospritzer with a U-tube 
system providing the wash (Khakh et al., 1995). 
 
Statistics. Pooled data are shown as means + SEM. 
 
Results 
Initial experiments were performed on transfection of the GluCl α and β subunits into 
HEK cells.  Robust responses to IVM (500 nM) were detected only in cells that expressed 
both the α and β subunits (Figure 2-2A and B).  Unlike recordings from Xenopus oocytes 
(Cully et al., 1994), the current was transient; however, when we used successive voltage 
ramps to measure the conductance and reversal potential of the current, we found that the 
conductance remained relatively constant and the reversal potential changed after 
application of IVM (Figure 2-2C and D).  In experiments not shown, we found that the 
IVM-induced conductance was stable for at least 30 min.  These results encouraged us to 
design and construct the Sindbis virus, vSinGluClαβΕGFP, which expressed three genes: 
GluClα, GluClβ, and GFP as a reporter for infected cells. 
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FIGURE 2-2 
 
Figure 2-2  GluCl α and β are both required for functional channels in HEK293 
cells. A, Voltage-clamp record of a HEK293 cell transfected with GluCl α and EGFP 
shows that this subunit alone does not respond to applications of 500 nM IVM.  5 out of 5 
cells showed no response to this subunit alone. B, Voltage clamp record of a HEK293 
cell transfected with GluCl α and β subunits shows a transient IVM-induced current.  5 
out of 5 cells transfected in this fashion showed a robust response to IVM. C, Voltage 
ramps from –90 mV to –40 mV before (arrow), during, and after the application of 500 
nM IVM.   The increasing slopes show the IVM-induced conductance.  The waveforms 
also show a clear change in reversal potential during the development of the conductance.  
Ramps 100 ms in duration were delivered at 1 s intervals.  D, Input resistance of the cell 
in panel C.  A conductance develops and then remains relatively constant after 
application of IVM. 
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The GluCl / IVM method suppresses neuronal excitability 
We infected 10 to 14 days-in-culture rat E18 hippocampal cultures with 
vSinGluClαβΕGFP or the control virus vSinEGFP.  As expected from previous studies 
(Khakh et al., 2001), the cultures were readily infected by either Sindbis virus, showing 
robust GFP expression in 20 to 50% of the neurons as early as 6 h post infection.  
Previous studies also show that Sindbis-infected neurons die after ~ 48 h, presumably 
because the virus recruits all the ribosomes of the cell and thereby effectively shuts off 
host protein synthesis (Frolov and Schlesinger, 1994; Perri et al., 2000); therefore, we 
carried out our experiments at 24 hours post infection.  Neurons infected with 
vSinGluClαβΕGFP and vSinEGFP had morphology indistinguishable from uninfected 
controls at this stage and appeared to be healthy (data not shown). 
In approximately 20% of GFP-positive cells infected with vSinGluClαβΕGFP, 
we detected a robust conductance increase upon application of 5 nM to 500 nM IVM 
(bottom panels of Figure 2-3A,B, and C).  The time to activate this current was dose-
dependent; the time constant decreased from 500 s  at 5 nM to 6 s at 500 nM.  
Surprisingly, the maximal conductance did not seem to vary in this concentration range.  
Also shown in the top panels of Figure 2-3 is the robust silencing effect of this 
conductance increase.  Spontaneously firing cells subject to application of IVM stopped 
firing action potentials, and the membrane potential moved to values between –50 and –
65 mV, which is near the value of ECl for solutions that we used.  Importantly, 
vSinEGFP-infected neurons and uninfected neurons showed no responses to IVM at 
these concentrations (data not shown).   
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FIGURE 2-3 
 
Figure 2-3: Activation of GluCl conductance by IVM over a 100-fold concentration 
range. 
(A, 500 nM; B, 50 nM; C, 5 nM).  Top panels show current-clamp data from cells that 
displayed spontaneous activity.  Bottom panels show input conductance measured with 
voltage-clamp ramps from –80 mV to –50 mV 200 ms in duration at intervals of 1 s.  
Each panel represents data from a different cell.  Uninfected and GFP-infected neurons 
had no response to IVM applied similarly. 
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Glutamate is the major excitatory transmitter in the brain, and brief applications of 
glutamate strongly elicit action potentials in hippocampal neurons (Storm-Mathisen, 
1981; Crunelli et al., 1983).  The major goal of the GluCl / IVM method is to insure that 
once a GluClαβ positive cell is activated by IVM, it no longer fires action potentials in 
response to excitatory input.  Figure 2-4A demonstrates this effect.  The left panel shows 
that an infected neuron fires volleys of action potentials in response to 10 ms pulses of 
100 μM glutamate; the right panel shows that, in the presence of 5 nM IVM, the same 
neuron no longer responds to identical glutamate pulses.  Below (Figure 2-8), we show 
that neurons expressing this invertebrate glutamate receptor display no changes in 
glutamate responses. 
Additionally, neurons infected with vSinGluClαβΕGFP and activated with IVM 
show extreme reductions in impulse firing elicited by direct current injection.  The top 
panel of Figure 2-4B shows current-clamp records from a vSinGluClαβΕGFP-infected 
neuron.  Increasing current pulses (up to 30 pA) elicit current-dependent firing.  The 
bottom panel shows records from a similar neuron, incubated with 5 nM IVM.  This 
neuron does not respond at all to the same current injection protocol.  Moreover, injection 
of up to 200 pA (data not shown) failed to elicit a spike.  Figure 2-4C shows the same 
experiments for an uninfected control cell; 5 nM IVM did not affect the excitability.  This 
lack of IVM effect was observed in all of 103 uninfected or 55 vSinEGFP-infected 
neurons, respectively. 
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FIGURE 2-4 
 
 
Figure 2-4.  IVM silences GluCl-expressing neurons. 
A, Silenced cells no longer respond to glutamate.  Current clamp traces from a GluCl 
infected cell.  Dots indicate 10 ms applications of 100 μM glutamate.  Left panel, prior to 
activation with IVM, the cell responds to glutamate with action potentials.  Right panel, 
after activation with 5nM IVM, the cell no longer responds to the same glutamate 
application.  One second applications of glutamate could produce a slight depolarization, 
but no action potentials (data not shown). B, GluCl infected cells in current clamp, 
showing responses to depolarizing current pulses (0 to 30 pA, 5 pA increments).  In 
control solutions, cells responded with action potentials; but the IVM (5 nM)-induced Cl- 
conductance prevented action potentials (bottom panel).  Cells remained silenced even in 
responses to current pulses as high as 200 pA (data not shown).  C, an uninfected cell, 
showing no reduction in excitability by 5 nM IVM. 
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Sindbis expression produces highly variable results 
Previous reports show large cell-to-cell variability in expression levels, based on 
measurements using dual promoters to express an ion channel subunit with Sindbis virus 
(Okada et al., 2001).  We expected similar cell-to-cell variability in our experiments.  
Unexpectedly, we found that the major variability in IVM responses occurred between 
culture dishes rather than within neurons in a given culture (Figure 2-5).  Each point in 
Figure 2-5 represents the average of five infected neurons in a single infected culture.  
Some cultures respond well while others do not.  We could observe no clear 
morphological differences or GFP fluorescence intensity differences between cultures 
that expressed well and those that expressed poorly.  We attempted, with no success, to 
minimize this variability by varying the age of the cultures, the time after infection, 
temperature and position in the incubator, preparation of the virus, sonication of the virus, 
and glutamate concentration in the culture medium.  In control dishes infected with 
vSinEGFP, there was no significant difference between the IVM+ and IVM- input 
conductance in any culture tested (data not shown).  Because of this culture-to-culture 
variation, we selected only cultures that had neurons responding well to IVM for the 
measurement studies presented above.  We found similar dish-to-dish variability in 
HEK293 cultures infected with vSinGluClαβEGFP, but not in HEK cultures transfected 
with both plasmids encoding the GluCl subunits; therefore we believe that this variability 
is a characteristic of the Sindbis expression system rather than an inherent limitation of 
the GluCl / IVM method. 
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FIGURE 2-5 
 
Figure 2-5: There is a large variation in expression levels that seems to be culture 
dependent.  Each point represents the average of 5 cells in a culture dish.  Roughly half 
of the cultures surveyed have no response to 500 nM IVM, and these cultures were 
excluded from the plot.  The points plotted here represent the cultures that do respond to 
500 nM IVM.  Note that this graph represents data taken at 0 and 5 nM IVM; the points 
have been spread out to enhance visualization.  The arrow represents average cell 
conductance in 0 nM IVM, 100 μM muscimol for comparison. 
38 
 
 
In Nupherin-mediated transfection, all fluorescent cells respond to IVM. 
We sought an expression method that could overcome the variability of the Sindbis 
system.  We employed the newly developed Nupherin-neuron transfection system to 
transfect GluCl channels into hippocampal cultures.  In these experiments, we modified 
the GluCl coding sequence to include fluorescent proteins (yellow fluorescent protein, 
YFP; and cyan fluorescent protein, CFP) in the M3-M4 loop of each construct (GluClα 
and β subunits, respectively, as shown in Figure 2-6A).  Figure 2-6C, D, and E show 
images from an exemplar hippocampal culture.  Each of 30 fluorescent cells in three 
cultures responded to 5 nM IVM with a conductance greater than 30 nS, similar to the 
results with neurons in responsive Sindbis infected cultures (Figure 2-6B).  This figure 
shows that neurons transfected with the GluCl α subunit alone do not develop a 
conductance in the presence of IVM.  The variability between cultures is substantially 
less with Nupherin-mediated expression than with Sindbis-mediated expression. 
 
IVM-induced Cl- conductance is reversible 
In previous reports, IVM has been described as acting irreversibly on GluCl channels 
expressed in Xenopus oocytes (Cully et al., 1994) on a time scale of several min.  Ligand 
binding experiments show that IVM does dissociate from its receptor (presumably the 
GluCl channels), with a rate constant of 0.005 - 0.006 min-1 (Cully and Paress, 1991).  
Therefore we sought to measure reversibility of IVM action on a time scale of several 
hundred min.  We infected cultures of hippocampal neurons, incubated in 5 nM IVM, and  
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FIGURE 2-6 
 
 
Figure 2-6: Neurons cotransfected with separate plasmids encoding EYFP-tagged 
GluCl α and ECFP-tagged GluCl β show fluorescence.   
 A, Cartoon indicating that the fluorescent protein was inserted in the M3-M4 loop 
of each subunit. 
 B, Measured input conductance of neurons transfected with the GluCl α-EYFP 
fusion and GluCl β-ECFP fusion. NT, neurons that have not been transfected; AB,  
neurons transfected with both subunits; A, neurons transfected with only the GluCl α-
EYFP subunit.  All bars represent data from three independent cultures, 10 cells per 
culture. 
 C, A brightfield image at 40x showing several neurons, with arrows indicating 
three neurons that have been transfected.  
 D, The field of view in panel B imaged with an ECFP filter set. 
 E, The field of view in panel B imaged with an EYFP filter set. 
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measured the input conductance of the neurons to verify that the channels were activated.   
We then washed the cultures, and recorded the input conductance after one hour or eight 
hours.  Figure 2-7 summarizes these results.  At 1 h, the conductance has not significantly 
changed from the activated conductance, whereas by eight hours, the conductance has 
returned nearly to baseline.  The final bar shows that IVM can subsequently reactivate the 
channels.  Formally, it is not possible to distinguish between the possibility that the 
reversibility is caused by IVM washing off the GluCl receptors or the possibility that the 
reversibility is due to receptor turnover, but the important feature here is that the 
technique appears to be reversible in terms of electrical activity. 
 
Neither GluCl expression nor IVM application affects other synaptic properties 
In experiments to examine possible unwanted additional effects of IVM, we employed 5 
nM IVM, since this concentration produces adequate silencing in most neurons.  Because 
of the homology between GluCl channels and GABAA receptors, we were concerned that 
one or both of these subunits might heteromultimerize with native GABAA receptor 
subunits.  We therefore compared the amplitude, rise time, and decay time of GABA-
evoked responses.  The left panel of Figure 2-8A shows that these three parameters do 
not significantly differ between infected and uninfected cells, providing confidence that 
heteromultimerization with GABA subunits did not take place or at least had no 
functional consequences.   After measuring the evoked responses, we applied 5nM IVM 
to these cultures to ensure that these cultures were expressing the GluCl receptor at high 
levels.  
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FIGURE 2-7 
 
Figure 2-7: IVM-induced chloride conductance deactivates several hours after IVM 
washout.  The input conductance of cells infected with vSinαβEGFP was first measured 
without IVM, and then in the presence of 5 nM IVM.  After 1 h of washing, there is little 
recovery in cell conductance, whereas after 8 h the conductance returns to uninfected 
levels.  The last bar shows that IVM-induced conductance can be reactivated.  Each bar 
represents 10 cells in two cultures and the error bars are standard errors. 
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FIGURE 2-8 
 
Figure 2-8: Expression of GluCl does not alter glutamate or GABA-evoked currents. 
A, Evoked currents were measured in GluCl-infected and uninfected neurons with 10 ms 
agonist puffs (100 μM GABA, 1 mM glutamate).  The amplitude, rise time, and decay 
time were measured.  The plot shows these three parameters relative to the measurements 
in uninfected cells.  GABA responses are shown in the left panel, glutamate responses on 
the right.  For each of the two ligands, the bars represent data pooled from 10 cells from 
two different cultures. B, C, analysis of GABA mIPSCs in the absence (B) and presence 
(C) of 5 nM IVM.  The peak amplitude histogram (top panel) and decay time histogram 
(bottom panel) are shown.  The amplitude data are shown in 10 pA bins and the decay 
time data are shown in 10 ms bins.  Note that there is no apparent difference in histogram 
shape between the 0 and 5 nM IVM case for either measurement.  In (B) data are pooled 
from 20 events each from 5 neurons in one culture, and in (C) data are pooled from 30 
events each from 5 neurons in one culture. 
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The GluCl α and β heteromultimer is a glutamate receptor (Cully et al., 1994).  
We were concerned that this response might add to or distort the endogenous glutamate 
response of the neuron.  The right panel of Figure 2-8A addresses these concerns in an 
experiment using Sindbis-mediated expression: the glutamate response did not change 
significantly between uninfected and GluClαβ expressing neurons.  As above, we used 
only cultures that responded well to IVM for these experiments.  These experiments were 
performed with CsCl in the internal recording solution and voltage-clamped at –60mV, 
so that any additional conductance caused by glutamate activation of GluCl would result 
in an increase in amplitude or perhaps an increase in decay time.  In infected cultures 
treated with CNQX and APV to block endogenous glutamate receptors, we found that 
steady application of 10 μM glutamate (the estimated steady concentration of glutamate 
in CSF) produced no detectable conductance increases (< 0.1 nS).  Steady application of 
2 mM glutamate, however, produced slow, large (~30 nS) conductances.  
IVM has various effects on other ion channels, including GABA (Krusek and 
Zemkova, 1994), P2X2 (Khakh et al., 1999), and nAChR (Krause et al., 1998).    These 
effects occur with concentrations of IVM higher than 5 nM.  However, we chose to study 
what we regard as the most likely side effect, GABA potentiation, with our target 
silencing IVM concentration of 5 nM.  Figure 2-8B presents histograms of the amplitude 
and decay time of the GABAergic synaptic miniature IPSCs (mIPSCs) recorded from 
uninfected neurons in the presence of the glutamate receptor blockers CNQX and APV 
and the Na+ channel blocker TTX.  Figure 2-8C presents the same type of data, with the 
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addition of 5 nM IVM in the recording media.  There is no apparent potentiation of 
GABA receptors at this concentration of IVM.  
 
Discussion  
We describe a procedure that combines advantages of genetically based and 
pharmacologically based silencing by inhibitory ion channels.  Our results demonstrate 
that the GluCl / IVM method modifies neuronal excitability in an inducible and reversible 
manner.   Expression of GluCl alone seems to leave the excitability of the neuron 
unaltered, and IVM application to uninfected neurons within the effective range for 
silencing GluCl expressing neurons never produces a detectable conductance.  However, 
many GluCl-expressing neurons display a reduction in excitability when exposed to low 
concentrations of IVM.  The reduction in excitability silences many neurons, and this 
silencing can be reversed by ~ 8 h of washing.  These are the desired results of the GluCl 
/ IVM silencing method.   
With the Sindbis virus construct, there was an inherently high level of variability 
of expression among infected cells.  Despite numerous attempts to understand and control 
this variability, we found no parameters to explain it.  Both HEK cells transfected with 
the GluCl α and β subunits, and Xenopus oocytes injected with RNA for this channel, 
nearly always show expression, reinforcing our belief that this variability results from an 
aspect of Sindbis viral biology.  Nupherin-mediated expression yields more consistent 
data, supporting this interpretation.  Because our long-term goal involves transgenic 
methods to express the GluCl channels, the variability does not appear to be a source of 
significant concern for the GluCl / IVM silencing method. 
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  Neurons expressing the channel at a high level are strongly silenced by 5 nM 
IVM.  This low concentration is important, for previous reports show that IVM at 
considerably higher concentrations in the mammalian brain is toxic.  Studies done with 
radiolabeled IVM in blood brain barrier-impaired mice indicate that the toxic 
concentration of IVM in the brain is ~ 500 nM (Schinkel et al., 1994), which is two 
orders of magnitude above the concentration we are using.  This gives us some 
confidence that in vivo applications of the GluCl / IVM method may succeed.  A related 
complexity is the delivery of IVM to the brain.  The blood-brain barrier contains 
mechanisms, primarily involving mdr1, that appear to pump IVM out of the brain, and 
this might prevent systemically applied IVM from reaching GluCl channels in the brain.   
However, a clinically relevant intraperitoneal dose, 0.2 mg/kg, results in 1.5 ng/g of IVM 
in brain tissue (Schinkel et al., 1994), or approximately 2 nM.  This is very close to the 
concentration we believe necessary for silencing neurons expressing GluCl.  Perhaps in 
vivo applications of the GluCl / IVM method will require relatively simple methods of 
IVM delivery to the animal.  Of course, more sophisticated options exist for easing drug 
delivery, such as using blood-brain disrupting drugs (Jette et al., 1995) or using mice with 
disrupted drug-pumping at the blood-brain barrier, as the foundation for transgenic mice 
expressing this channel. 
Previous reports suggest that IVM “irreversibly” activates GluCl channels, an 
unusual situation for ligand-gated channels.  The impression of irreversibility may arise 
from the limited time scale of previous experiments on Xenopus oocytes, or from drug 
retention by the large yolk volume of the cells.  Data from our washout experiments 
(Figure 2-7), suggesting reversibility after 8 h, are roughly consistent with the 
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disassociation constant determined in biochemical binding experiments (Cully and 
Paress, 1991).  Both the onset and recovery from silencing will depend on the 
pharmacokinetics of IVM in the animal; for instance, IVM can be stored in the fat. 
In addition to the channel-based silencing strategies noted in the Introduction, 
other investigators have utilized genetic manipulations of synaptic transmission, for 
instance utilizing tetanus toxin (Baines et al., 2001).  It is unclear whether tetanus toxin-
based procedures are reversible.  Additionally, exogenous expression of K+ channels has 
been used to modulate biochemical signaling pathways in HEK293 cells (Holmes et al., 
1997). 
There are several potential applications for the GluCl / IVM method, or for 
improved versions, in research and in therapeutics.  One application would involve cell-
specific expression of GluCl channels under the control of appropriate promoter(s).  This 
strategy may enable genetic manipulation of excitability at selected times in development 
and in specific regions in the CNS.  The requirement for both the GluCl α subunit and the 
GluCl β subunit may at first seem like a complication; however, this gives the 
experimenter the flexibility to use different promoters to drive the two genes, so that only 
neurons in which both promoters are active will be silenced upon administration of IVM.  
Additionally, it may be possible to construct viruses with these two genes that can be 
used in vivo.  Stereotaxic injection of such viruses may then circumvent the need for 
promoters that drive expression in specific brain nuclei.  From a clinical standpoint, a 
targeted and controlled “excitability modulator” may form the basis for new treatments of 
epilepsy, chronic pain, or other diseases arising from excess neuronal activity.  It may be 
possible to titrate silencing by varying the dose of IVM. 
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C h a p t e r  3  
Selective elimination of glutamate activation and 
introduction of fluorescent proteins into a C. elegans 
chloride channel 
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Abstract 
 
    Glutamate-gated (GluCl) chloride channels from invertebrates can be activated by 
ivermectin (IVM) to produce electrical silencing in mammalian neurons. To improve this 
GluCl/IVM strategy, we sought to mutate the C. elegans GluCl channels so that they 
become insensitive to glutamate but retain their sensitivity to IVM. Based on structure-
function studies of nAChR superfamily members, we tested in oocytes 19 point mutants 
at 16 residues in the β subunit likely to be involved in the response to glutamate.  Y182F 
reduces the glutamate response by greater than 6 fold, with little change to IVM 
responses, when coexpressed with WT GluCl α.  For GluCl αβ(Y182F), the EC50 and 
Hill coefficient for glutamate is similar to those of WT, indicating that the mutant 
decreases the efficacy of glutamate, but not the potency.  Also, fluorescent proteins 
(EGFP, EYFP, ECFP; XFP) were inserted into the M3-M4 loop of the GluCl α, β and 
β(Y182F).  We found no significant functional difference between these XFP-tagged 
receptors and WT receptors.  The modified GluCl channel, without glutamate sensitivity 
but with a fluorescent tag, may be more useful in GluCl silencing strategies. 
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Introduction 
    Several recent studies describe expression of exogenous ion channels in order to 
change the electrical properties of neurons (Johns et al., 1999; Sutherland et al., 1999; 
Nadeau et al., 2000; Falk et al., 2001; Okada et al., 2001; Scearce-Levie et al., 2001; 
White et al., 2001a; White et al., 2001b).  Our laboratory has developed a procedure that 
employs the glutamate-gated chloride (GluCl) channels from C. elegans (Cully et al., 
1994; Xue, 1998; Slimko et al., 2002).  Because the anthelminthic ivermectin (IVM) 
activates these channels at concentrations too low to affect other mammalian ion 
channels, it is possible to envision a procedure that selectively silences the target neurons.  
The GluCl channels would be expressed in the target neurons either by local injection of 
viral vectors or in transgenic animals under cell-specific promoters. 
    The GluCl/IVM technique could be improved in two ways.  First, the GluCl channels 
should be rendered insensitive to glutamate, which is present in CSF and released during 
synaptic transmission.  Second, the expression of the GluCl channels should be 
physically verifiable by a technique that has higher throughput than electrophysiology.  
Fluorescent proteins are widely employed for such purposes; and the channels could be 
fused to fluorescent proteins. 
    We chose the GluCl channels in part because they are members of the nicotinic 
receptor superfamily, which has been widely studied by mutagenesis (Corringer et al., 
2000).  Therefore several precedents suggest ways to re-engineer the GluCl channels 
(Etter et al., 1999; Dougherty and Lester, 2001; Han et al., 2001).  For the goal of 
eliminating glutamate responses while retaining IVM responses, one considers the 
residues in the N-terminal region known to bind agonists (Figure 3-1) (Pedersen et al., 
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1986; Curtis et al., 2000).  For the goal of introducing fluorescent proteins, previous 
results suggest that the intracellular loop between the M3 and M4 domains is the 
appropriate region (Gensler et al., 2001).     
 
Materials and Methods 
Mutagenesis  
    Wild type C. elegans GluCl α and GluCl β  genes (Cully et al., 1994) cloned into 
pBluescript II SK+ were a gift from Merck Research Laboratories.  In our present study 
(Slimko et al., 2002), they were cloned into pcDNA 3.1 (ClonTech, Palo Alto, CA) with 
KpnI and Not I.  Site-directed mutagenesis was performed on the GluCl β subunit using 
the QuikChange mutagenesis kit (Stratagene, La Jolla, CA), and the mutations were 
confirmed by sequencing. 
2.2 Fluorescent protein-tagged constructs 
    Green fluorescent protein (EGFP), yellow fluorescent protein (EYFP), and cyan 
fluorescent protein (ECFP) were obtained from ClonTech (Palo Alto, CA).  The PCR 
primers 5’-TCCACCGGGCCGGCAAATGGTGAGCAAGGGC-3’ and 5’-
GTCGCGGCGCCGGCGCTTGTACAGCTCGTCCA-3’ were used to PCR amplify 
EYFP or EGFP, and the resultant PCR product was ligated into the NgoMIV site of 
GluCl α, which positions the tag immediately after the arginine at residue 408, the 49th 
out of 73 residues in the M3-M4 loop.  The PCR primers 5’-
CACCGGTCTTCGAAATGGTGAGCAAGGGC-3’ and 5’-
TCGCGGCCTTCGAACTTGTACAGCTCGTCC-3’ were used to PCR amplify ECFP, 
and the resultant PCR product was ligated into the Csp45I site of GluCl β, which 
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positions the tag immediately after the phenylalanine at residue 373, the 43rd out of 69 
residues in the M3-M4 loop. 
Expression of GluCl cRNAs 
    The cDNAs were linearized by NotI. All cRNAs were transcribed in vitro using the T7 
mMESSAGE mMACHINE kit (Ambion, Austin, TX) as appropriate. RNAs were then 
quantitated by RiboGreenTM RNA Quantitation Kit (Molecular Probes, Eugene, OR). 
Stage V to VI Xenopus laevis oocytes were harvested and injected with 50 nl/oocyte of a 
mixture containing 25 to 375 pg per subunit of cRNAs for wild-type, mutant and XFP 
constructs, in equimolar amounts of α and β. The size of the XFP coding region is ~ 0.7 
kb and that of the GluCl subunits is ~ 1.4 kb, thus 1.5 times greater mass of an XFP-
tagged subunit cRNAs was injected compared with WT subunits.  After injection, 
oocytes were incubated at 18 °C in ND-96 solution (96 mM NaCl, 2 mM KCl, 1 mM 
MgCl2, 1.8 mM CaCl2 and 5 mM HEPES, pH 7.5, osmolarity 230 mOsm) supplemented 
with 50 μg/ml gentamicin, 2.5 mM pyruvate and 0.6 mM theophylline. 
Electrophysiology 
    Recordings were carried out 24 to 36 h after injection. Membrane potential was held at 
–60 mV in Ca2+-free ND-96 with two electrodes (filled with 3 M KCl, resistance 0.5–3 
MΩ) using a GeneClamp 500 circuit and a Digidata 1200 digitizer from Axon 
Instruments, Inc. (Foster City, CA) interfaced with an IBM-compatible PC running 
pCLAMP 8.0 software from Axon. Drugs were applied with a dead time of 1 s. Typical 
drug application times for glutamate and IVM were 10 s and 30 s, respectively. 
Experiments were conducted at room temperature (22 °C). Ivermectin was stored frozen 
as a 10 mM stock solution in dimethyl sulfoxide for up to 2 weeks. When dissolved into 
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the perfusion solution, the final concentration of dimethyl sulfoxide was no more than 
0.1%. Glutamate was also prepared from stock solution at concentration of 100 mM (in 
water).  
Data Analysis 
    The glutamate dose-response relations were measured by applying a series of 
glutamate concentrations to each oocyte.  Because IVM responses did not reverse on the 
time scale of the experiments, only a single concentration was applied to each oocyte.  
This response was normalized to the amplitude of the response to 5 μM IVM in oocytes 
(a saturating concentration) of the same batch.  Glutamate and IVM responses to various 
drug concentrations were fitted to the Hill equation by a nonlinear routine, 
I/Imax = 1/(1 + (EC50/[A])n), where I is agonist-induced current at concentration [A], Imax 
is the maximum current, EC50 is the concentration inducing half-maximum response, and 
n is the Hill coefficient. Statistical analyses were performed using unpaired two-
population Student’s t test (as appropriate), with a significance level of p < 0.05. All Data 
were presented as mean ± S.D.  
Drugs and restriction endonucleases 
    Glutamate and IVM were purchased from Sigma (St. Louis, MO); Csp45I was 
purchased from Promega (Madison, WC); and all the other restriction endonucleases 
were purchased from New England Biolabs (Beverly, MA). 
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Results and Discussion 
Mutations in the ligand-binding domain and M1 of GluCl β  
    To eliminate sensitivity to glutamate, we mutated the GluCl β subunit, because this 
subunit is required for glutamate sensitivity (Cully et al., 1994). Glutamate-gated chloride 
(GluCl) channels are members of the nicotinic acetylcholine receptor (nAChR) 
superfamily (Xue, 1998). Based on structure-function studies of the glycine receptor 
(Shan et al., 2001) and the crystal structure of the ACh binding protein (Brejc et al., 2001; 
Dougherty and Lester, 2001), we identified 16 residues likely to be involved in the 
response to glutamate but not to IVM.  
    Figure 3-1 shows the alignment between GluCls and four other nAChR family 
members. Residues in red type are completely conserved; green and blue type denotes 
partial conservation. The first two Cys residues define the “signature loop” common to all 
nAChR superfamily subunits, and the second two Cys define Loop C (nAChR 
terminology). Y182 in the GluCl β subunit, aligns with W149 at nAChR, the site of a 
cation-π interaction with the ligand (Zhong et al., 1998; Brejc et al., 2001). T229 and 
Y232 align with the crucial nAChR Y190 and Y198, respectively. The glycine receptor is 
the closest homolog of GluCls in vertebrates. Relevant site-directed mutagenesis 
experiments on human glycine receptors indicate that I244A eliminates glycine 
sensitivity but retains IVM sensitivity (Shan et al., 2001). I269 at the GluCl β subunit 
aligns with this position.  These 4 residues were mutated in the first round (highlighted in 
yellow, Figure legends, Figure 3-1). The mutations Y182A and Y232A abolished both 
glutamate and IVM responses; at these residues, we then performed 4 “milder” mutations 
(Y→F, W).  We have not succeeded in generating a cDNA for Y232F.  
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FIGURE 3-1 
 
Figure 3-1: GluCl sequences in the extracellular ligand-binding domain and M1, 
compared with other nAChR superfamily members. The C. elegans GluCl β subunit 
and α subunit (c GluCl β; c GluCl α; GenBank accession numbers U14525 and U14524) 
were aligned with each other and the human glycine receptor α1 subunit (h GlyR α1; 
Swiss-Prot P23415), mouse GABA receptor β2 subunit (m GABA β2; Swiss-Prot 
P15432), human α1 nicotinic acetylcholine receptor subunit (h Ach α1; Swiss-Prot 
P02708) and human 5-HT3A subunit (h 5-HT3A; Swiss-Prot P46098), using MULTALIN 
(http://pbil.ibcp.fr/cgi-bin/align_multalin.pl).  The first two Cys residues define the 
signature loop common to all nAChR superfamily subunits, and the second two Cys 
define Loop C in nAChR. Sixteen highlighted residues on GluCl β were mutated to 
alanine. At Y182 and Y232 (yellow residues), tyrosine was also mutated to phenylalanine 
and tryptophan. Y182 aligns with W149 at nAChR, the site of a cation-π interaction with 
the ligand. T229 and Y232 (yellow residues) align with the crucial nAChR Y190 and 
Y198, respectively. I269 aligns with I244 in glycine receptor. Six additional mutations to 
alanine in Loop C were performed, where the residue is not glycine.  The other 6 residues 
are basic in GluCl α and GluCl β but not in the other receptors, suggesting they may 
interact with the acidic group of glutamate. These residues were also mutated to alanine.  
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    We also generated and analyzed 6 additional X→A mutations in Loop C (Vandenberg 
et al., 1993; Rajendra et al., 1995), where X is not glycine (highlighted in green, Figure 
legends, Figure 3-1). They are T224A, S225A, H226A, T227A, N228A and S231A. Red 
residues in Figure 3-1 (R66, K70, R131, K202, K236 and K242) are basic in GluCl α and 
GluCl β, but not in the other receptors, suggesting that they may interact with the acidic 
group of glutamate; we mutated these residues to alanine as well. 
 
Glutamate and IVM responses of WT GluCl receptors 
    Heteromeric receptors expressed robustly after injections of 25 pg each of cRNA for 
the GluCl α and β subunits (termed WT).  Response amplitudes were 304 ± 18 nA (n = 
33) to 1 mM glutamate and 675 ± 26 nA to 1 μM IVM (n = 26).  Figure 3-2 (top panel) 
presents an example of WT responses to the agonists. 1 mM glutamate induced a rapid 
and reversible current (348 nA) while 1 μM IVM induced a slow and irreversible current 
(596 nA).  The EC50 and the Hill coefficient for WT are 0.48 ± 0.08 μM and 1.76 ± 0.31 
for IVM and 0.32 ± 0.05 mM and 1.69 ± 0.07 (n = 6) for glutamate, respectively.  
    As expected from previous data (Cully et al., 1994), responses were much smaller for 
equivalent injections of individual cRNAs, which presumably encoded homomeric 
receptors.  When 25 pg cRNA of GluCl α or GluCl β was injected, the average responses 
to 1 μM IVM or 1 mM glutamate were 24 ± 6 nA (n = 6) or 79 ± 8 nA (n=10), 
respectively, some tenfold smaller than the heteromeric responses.  Responses were 
considerably larger with injection of 250 pg cRNA for the individual subunits.  Oocytes 
injected with 250 pg GluCl α cRNA displayed an IVM dose-response relation with an 
EC50 of 0.52 ± 0.06 μM, a Hill coefficient of 2.24 ± 0.35, and maximal responses of 1.68 
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FIGURE 3-2 
 
Figure 3-2: Electrophysiological characterization of WT and three mutated GluCl 
constructs.   Left-hand column, responses to 1 mM glutamate (GLU); right-hand 
column, responses to 1 μM ivermectin (IVM); the latter are slower than the glutamate 
responses and irreversible on the time scale of the experiments.  The top row shows 
responses in an oocyte injected with GluCl αβ(WT) from C. elegans.  Oocytes injected 
with GluCl αβ(I269A) responded well to both glutamate and IVM.  The αβ(Y182A) 
mutant GluCl abolished both glutamate and IVM responses.  The bottom row shows 
glutamate sensitivity was abolished but IVM sensitivity was retained in GluCl 
αβ(Y182F). For each mutant, the two traces shown were obtained from one oocyte. 
Horizontal line over the traces indicates the application time of agonists.  Xenopus 
oocytes were injected with 25 pg of both WT α RNA and WT (or mutated) β RNA. 
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± 0.25 μA (n = 8); there was little or no response to glutamate.   For injections of 250 pg 
GluCl β cRNA, the responses to glutamate displayed an EC50 of 0.24 ± 0.01 mM, a Hill 
coefficient of 1.56 ± 0.28 (n=5), and maximal response of 0.90 ± 0.13 μA (n = 15); 
responses to IVM were small or absent.  The homomeric receptors showed more rapid 
kinetics (activation, desensitization and deactivation) than the heteromeric responses; we 
did not study this phenomenon systematically.     
 
Glutamate and IVM responses at mutant receptors  
    In our first round of mutagenesis experiments, 4 constructs were tested in oocytes. 
GluCl αβ(T229A) and GluCl αβ(I269A) responded like WT: no significant difference 
was found (p > 0.05, n = 20). Figure 3-2 (second row) shows the currents induced from 
an oocyte injected with GluCl αβ(I269A), 360 nA and 710 nA for glutamate and IVM, 
respectively. On the other hand, GluCl αβ(Y182A) and GluCl αβ(Y232A) abolished 
both glutamate and IVM sensitivities (Figure 3-2, third row).  
    Fifteen additional mutants were examined in the second round (summarized in Table 
1).  Mutations to Ala (X→A) at H226, T227, N228, or S231 did not affect functional 
expression (p > 0.05, n = 6); mutations of T224, R131 or K202, did not affect glutamate 
response but modestly reduced (2-3 fold) the IVM response; and mutations at R66, K70, 
R236 and K242 decreased both glutamate and IVM responses. Mutations (Y→W) at 
Y182 and Y232 also destroyed both glutamate and IVM sensitivities. GluCl αβ(S225A) 
significantly increased the glutamate response to 223% of WT levels (p < 0.05, n = 6).  
Thus, none of these mutations achieved the desired results. 
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TABLE 3-1 
 
Table 3-1: Summary of glutamate and ivermectin effects on WT and mutant GluCls. 
All mutants were in the β subunit. All values were averaged from at least 5 oocytes. For 
those mutants examined in more than 2 batches of oocytes, data are presented as mean ± 
S.E.M.   
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GluCl αβ(Y182F) eliminates glutamate responses while retaining IVM responses 
    At position Y182 of the GluCl β subunit, 3 mutations were constructed (Y→A, W, F). 
The mutants GluCl αβ(Y182A) and GluCl αβ(Y182W) abolished the response of both 
glutamate and IVM.  However, GluCl αβ(Y182F) meets our requirement. An example is 
shown in Figure 3-2 (bottom row). 1 mM glutamate induced a tiny current (~ 5 nA) in the 
oocyte that expressed GluCl αβ(Y182F), while 1 μM IVM induced a current of 827 nA.  
On average, Y182F, when coexpressed with WT GluCl α, reduced the glutamate 
response to 15.8 ± 3.4% of WT levels but hardly changed IVM responses (106 ± 27%) (n 
= 78) (Figure 3-3A). For GluCl αβ(Y182F), the EC50 and Hill coefficient for glutamate is 
0.32 ± 0.05 mM and 1.33 ± 0.25 (n = 5), respectively, similar to those of WT (0.36 ± 0.04 
mM; 1.78 ± 0.22, n = 6) (Figure 3-3B), indicating that the mutant decreases the efficacy 
of glutamate, but not the potency. 
    Tyr-182 aligns with nicotinic receptor residue Trp149, which plays an important role 
in a cation-π interaction with the quaternary ammonium moiety of acetylcholine (Zhong 
et al., 1998; Brejc et al., 2001).  We conclude that this residue also plays an important 
role in the binding or response to both glutamate and IVM in the GluCl β subunit.  The 
interaction with both ligands is abolished by mutating the Tyr to Ala or to Trp, but only 
the interaction with glutamate is weakened by mutations to Phe.  The available data did 
not allow a decision about the nature of the moiety that interacts with Tyr182, or the 
nature of the interaction.   
 
 Functional Expression of fluorescent protein-tagged constructs  
    Three fluorescent proteins (EGFP, EYFP, ECFP; XFP) were separately inserted into  
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FIGURE 3-3 
 
Figure 3-3: GluCl αβ(Y182F) eliminates glutamate sensitivity and retains ivermectin 
sensitivity. A, GluCl αβ(Y182F) reduces the glutamate response to 15.8 % of WT levels 
but hardly changes IVM responses (106% of WT values). The values were pooled from 
78 oocytes of 6 batches, injected with 25 pg to 250 pg of cRNA for each subunit. Error 
bars are S.E.M. B, normalized glutamate dose-response relations for WT and GluCl αβ 
(Y182F). For GluCl αβ (Y182F) (open symbols, dashed line), the curve represents an 
EC50 of 0.32 mM and an nH of 1.33 (n = 5), similar to those of the WT GluCl αβ (closed 
symbols, solid line) (0.36 mM; 1.78, n = 6). 
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the M3-M4 loop of the GluCl α, β and β(Y182F). Firstly, functional expression of GluCl 
α(GFP), GluCl α(YFP), GluCl β(CFP) and GluCl β(Y182F)(CFP) were expressed as 
homomers in oocytes and compared with GluCl α, β and β(Y182F), respectively.  No 
significant difference was observed (p > 0.05, n > 6, data not shown). Then heteromers 
with XFP tags in only the α or β subunit constructs were examined.  Data for one of these 
constructs are given in Figure 3-4A. No significant difference was found between GluCl 
αβ(Y182F) and GluCl αβ(Y182F)(CFP) (p > 0.05, n = 9).  Like GluCl αβ(Y182F), 
GluCl αβ(Y182F)(CFP) abolished the glutamate response to 10.9% of the WT level and 
almost kept the IVM response (84.6% of the WT level) (n = 7). Finally, doubly-XFP-
tagged constructs were expressed to the oocytes. Three different molar concentrations of 
RNA were compared with WT and XFPs. There is no significant difference (p > 0.05, n > 
6) between the responses in oocytes injected with equal molar concentration of WT and 
XFP RNA (Figure 3-4B).  The grand averaged data from 30 oocytes showed that XFP 
hardly changed the response to both glutamate and IVM (90.8 ± 14.2% and 92.0 ± 7.1% 
of WT level, respectively) (Figure 3-4C). The re-engineered GluCl channel, without 
glutamate sensitivity but with a fluorescent tag, may be more useful in GluCl silencing 
strategies. 
Critique of the GluCl/IVM strategy 
Channel-based silencing strategies could mimic either the endogenous inhibition arising 
from activation of K+ channels (for instance, GABAB receptors coupled to GIRK 
channels) or that arising from activation of Cl− channels (for instance, GABAA 
receptors). Most strategies employ K+ channels (Johns et al., 1999; Sutherland et al., 
1999; Nadeau et al., 2000; Falk et al., 2001; Scearce-Levie et al., 2001; White et al.,  
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FIGURE 3-4 
  
 
Figure 3-4.  Functional expression of fluorescent protein-tagged constructs. A, 
comparison among GluCl αβ, αβ(Y182F) and αβ(Y182F)(CFP). No significant 
difference is found between the functional expression of β(Y182F) and β(Y182F)(CFP). 
All values were averaged from 6 to 9 oocytes. Error bars are S.E.M and asterisks 
represent significant difference between 2 groups (P<0.05). Oocytes were coinjected with 
25 pg WT α RNA and 25 pg WT β, β(Y182F) or 37.5 pg β(Y182F)(CFP) RNA, 
respectively. B,bar plots compare WT and GluCl α(GFP)β(CFP) (termed XFP). There is 
no significant difference (P > 0.05) between the responses in oocytes injected with equal 
molar concentration of WT and XFP RNA. C, grand average from 30 oocytes injected 
with 3 concentrations (25 pg, 100 pg and 250 pg for each subunit of WT; 37.5 pg, 150 pg 
and 375 pg for each subunit of XFP). The glutamate and IVM responses of XFP are 
90.8% and 92.0% of WT levels, respectively.  
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2001a; White et al., 2001b; Lechner et al., 2002). K+ channels have the advantage that 
they can be chosen, or modified, to display various voltage-dependent and rectifying 
characteristics. K+ channels have the disadvantage that sustained K+ efflux (or Na+ entry) 
causes apoptosis under some circumstances (Nadeau et al., 2000).  
The GluCl/IVM strategy (Slimko et al., 2002) is, to our knowledge, unique among 
artificial silencing strategies because it employs Cl− channels. In most cells, intracellular 
[Cl−] is on the order of a few mM; as a result, if GCl rises, intracellular Cl− is expected to 
be driven by the K+ gradient. Therefore a high Cl− conductance is expected to clamp the 
cell near EK, or slightly hyperpolarized from the normal resting potential, and to cause 
only minor changes in intracellular Cl−. One possible disadvantage to this strategy 
involves such neurons as dorsal root ganglia neurons and many immature central nervous 
system neurons, whose complement of transporters leads to a relatively high intracellular 
Cl− and therefore a depolarized ECl. In such a cell, the GluCl/IVM strategy might cause 
ECl and EK to approach each other, possibly leading to KCl loss and to cell shrinkage. It is 
encouraging that in previous experiments on dorsal root ganglion cells, a heterologously 
expressed, continuously active Cl− conductance did cause a hyperpolarizing shift in ECl, 
but neither shrank nor killed the cells (Staley et al., 1996). 
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C h a p t e r  4  
Codon optimization of C. elegans GluCl ion channel 
genes for mammalian cells dramatically improves 
expression levels 
 
 
 
Text of this chapter is reproduced, with minor editing, from: 
 
Slimko EM, Lester HA (2003). Codon optimization of C. elegans GluCl ion channel 
genes for mammalian cells dramatically improves expression levels. J Neurosci 
Methods 14: 75-81 
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Abstract 
 
Organisms use synonymous codons in a highly non-random fashion.  These codon usage 
biases sometimes frustrate attempts to express high levels of exogenous genes in hosts of 
widely divergent species.  The C. elegans GluClα1 and GluClβ genes form a functional 
glutamate and ivermectin-gated chloride channel when expressed in Xenopus oocytes, but 
expression is weak in mammalian cells.  We have constructed synthetic genes that retain 
the amino acid sequence of the wild-type GluCl channel proteins, but use codons that are 
optimal for mammalian cell expression.  We have tagged the native and codon-optimized 
GluCl cDNAs with enhanced yellow fluorescent protein (EYFP, GluClα1 subunit) and 
enhanced cyan fluorescent protein (EFCP, GluClβ subunit), expressed the channels in 
E18 rat hippocampal neurons, and measured the relative expression levels of the two 
genes with fluorescence microscopy as well as with electrophysiology.  Codon 
optimization provides a six- to nine-fold increase in expression, allowing the conclusions 
that the ivermectin-gated channel has an EC50 of 1.2 nM and a Hill coefficient of 1.9.  We 
also confirm that the Y182F mutation in the codon-optimized β subunit results in a 
heteromeric channel that retains the response to ivermectin while reducing the response 
to 100μM glutamate by seven-fold.  The engineered GluCl channel is the first codon-
optimized membrane protein expressed in mammalian cells and may be useful for 
selectively silencing specific neuronal populations in vivo. 
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Introduction 
 
Comparative genomic studies show that organisms use synonymous codons in a 
nonrandom, species-specific fashion (Bernardi, 1985; Nakamura et al., 1996; Kanaya et 
al., 2001).  In E. coli, this non-random codon usage appears to parallel expression levels 
of the cognate tRNAs (Ikemura, 1981a, b).  Several authors suggest that high-level 
expression of genes containing non-optimal codons may be limited by the availability of 
tRNA for rare codons (Kane, 1995).  Codon optimization strategies enable the high-level 
expression of therapeutically relevant human proteins in E. coli (Hernan et al., 1992; 
Makrides, 1996), and in the yeasts P. pastoris and S. cerevesiae (Woo et al., 2002).  
There are fewer examples in which genes from evolutionarily old organisms have been 
optimized for expression in mammalian cells.  Three successful examples include the 
optimization of green fluorescent protein from the jellyfish A. porins (Haas et al., 1996), 
the tetracycline transactivator from E. coli (Wells et al., 1999), and Cre recombinase 
(Shimshek et al., 2002).  To date, there are no publications describing codon optimized 
membrane bound proteins.   
We are developing a strategy that selectively and reversibly silences specific 
neuronal subpopulations in mammals via expression of the GluClα1 and GluClβ genes 
from C. elegans (Li et al., 2002; Slimko et al., 2002); and we seek high-level expression 
of these two genes within mammalian neurons.  Genes in the GluCl gene family are 
found in many invertebrates and are part of the nicotinic receptor superfamily, 
characterized by a large extracellular N-terminus, four transmembrane domains, and a 
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large loop between the third membrane spanning segment (M3) and the fourth segment 
(M4) (Cully et al., 1994).  Many GluCl receptors are activated by the anthelminthic drug 
ivermectin (IVM), which is used both in humans and animals to treat a variety of 
parasitic diseases (del Giudice, 2002; Winnen et al., 2002).  Our strategy is to express 
both GluClα1 and GluClβ in specific neurons using tissue-specific promoters in 
transgenic animals or through local injection of viruses engineered to express these 
genes.  Systematic administration of IVM will then reversibly activate a chloride 
conductance in the target neurons, reducing their excitability.   
We are optimizing this GluVl / IVM strategy.  First, the wild type GluCl channel 
genes seem to express poorly in mammalian neurons.  While the weak expression appears 
partially due to the multi-subgenomic promoter Sindbis virus expression system (Slimko 
et al., 2002), we asked whether some of the problem arises from suboptimal codon usage.  
We have synthesized genes with codon usage similar to a compendium of highly 
expressed mammalian genes.  Because previous work showed that tagging the channels 
with fluorescent proteins in the M3-M4 loops provides a convenient assay for membrane 
expression but does not alter function of the receptor (Gensler et al., 2001; Li et al., 
2002), we also incorporated enhanced yellow and cyan fluorescent proteins (EYFP and 
ECFP) in the wild type and optimized genes.  We find that codon optimization alone 
generates nearly a six- to nine-fold increase in the fluorescence, indicating a much higher 
expression level.  We also present electrophysiological data that correlates with the 
fluorescence measurement.   
A second GluCl optimization tactic requires minimizing the endogenous 
glutamate response of these channels with no decrease in the IVM response.  We 
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previously showed that the Y182F mutation to the β subunit (Li et al., 2002) produces the 
desired abolition of glutamate but not IVM responses in an oocyte expression system.  
However, robust GluCl responses require IVM concentrations some 100-fold higher in 
oocyte systems than in mammalian cells.  We therefore tested whether these desirable 
pharmacological characteristics also hold for the codon-optimized Y182F GluClβ 
channel expressed in mammalian neurons.  Indeed, this seems to be the case. 
 
Material and methods 
Molecular Biology. The codon-optimized cDNAs (optGluClα1 and optGluClβ) were 
synthesized by Entelechon GmbH (Regensburg, Germany) and cloned into 
pcDNA3.1/TOPO-HIST from Invitrogen (Carlsbad, CA).  EYFP was amplified by PCR 
from pEYFP-N1 from ClonTech (Palo Alto, CA) with the primers 5’-
ACCGGTGAATTCCATGGTGAGCAAGGGCGAGGAG-3’ and 5’-
GCGGCCGGAATTCTTGTACAGCTCGTCCATGC-3’ and cloned into the EcoRI site 
of optGluClα1.  ECFP was amplified by PCR from pECFP-N1 from ClonTech with the 
primers 5’-GATGGTGAGCAAGGGCGAGGAG-3’ and 5’-
GTCTTGTACAGCTCGTCCATGCCG-3’ and cloned into the PmlI site of optGluClβ. 
The wild type fusion genes GluClα1-EYFP and GluClβ -ECFP have previously been 
described (Li et al., 2002).  The mutation Y182F of optGluClβ was performed using 
Stratagene’s QuikChange mutation kit with the following primers: 5’-
TGCAACTTCGACCTGGTGTCCTTCGCCCACACCATGAACGACATC-3’ and 5’-
GATGTCGTTCATGGTGTGGGCGAAGGACACCAGGTCGAAGTTGCA-3’.  The 
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sequences for the optimized genes (described in Results) have been deposited in 
GenBank, accession number AY195802 for optGluClα1 and AY195803 for optGluClβ.  
 
Neuronal culture and transfection. One μg DNA of each tagged subunit was incubated 
with 20 μg of Nupherin-neuron (BioMol Research Laboratories, Plymouth Meeting, PA) 
in 400 μl of Neurobasal medium without phenol (Invitrogen, Carlsbad, CA), while 10 μl 
of Lipofectamine 2000 (Invitrogen) was mixed in 400 μl Neurobasal.  After 15 min, the 
two solutions were combined and incubated 45 min.  E18 rat hippocampal neuronal 
cultures in 35 mm culture dishes, at least 14 days in culture, were incubated in the 
resulting 800 μl mixture for 2 - 4 h, and then the mixture was removed and replaced with 
the original 2 ml medium.  Recordings were made 24-48 h later. 
 
Electrophysiology. The bath solution was (in mM): 110 NaCl, 5.4 KCl, 1.8 CaCl2, 0.8 
MgCl2, 10 HEPES, and 10 D-glucose, pH 7.4, osmolarity 230 mOsm. Patch pipettes were 
filled with a solution containing (in mM): 100 K gluconate, 0.1 CaCl2, 1.1 EGTA, 5 
MgCl2, 10 HEPES, 3 ATP, 3 phosphocreatine, and 0.3 GTP, pH 7.2, 215 mOsm. For 
studying glutamate responses, 100 mM CsCl replaced the K gluconate in the pipette 
solution and 100 μM CNQX was added to the bath and drug perfusion solution.  Whole-
cell voltage clamp was maintained using an Axopatch-1D amplifier controlled by a 
personal computer running pCLAMP 8 software via a Digidata 1200 interface (Axon 
Instruments, Union City, CA).  Data were filtered at 2 kHz and digitized at 5 kHz.  
Holding potential was –60 mV.  Input conductance was measured by a 5 mV 
hyperpolarizing pulse.  100 μM glutamate was applied focally to single voltage-clamped 
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neurons using a Picospritzer with a U-tube system providing the wash (Khakh et al., 
1995).  Under these conditions, the chloride current measured upon GluCl activation was 
inward. 
 
Imaging. 24 h after transfection with the various combinations of constructs, cells were 
fixed by a 20-minute incubation in PBS with 4% paraformeldyhde and mounted in 
Vectashield H-1000 (Vector Laboratories, Burlingame, CA).  Neurons were then imaged 
with a 100x objective using the EYFP filter set XF104-2 (Omega Optical, Brattleboro, 
VT) or the ECFP filter set XF114-2 and the pixel intensity was averaged over the soma 
for each neuron. 
 
Statistics. Pooled data are shown as means + SEM. 
 
Results 
Codon optimization 
We used a compendium of 52 highly expressed mouse genes (ribosomal proteins, 
polymerases, elongation factors, and heat-shock proteins) to create the mouse codon 
usage table shown in Figure 4-1 (Sakai et al., 2001).  The codon adaptation index (CAI) 
quantifies the similarity between the codon usage of a specific gene and a species of 
interest (Sharp and Li, 1987).  Table 4-1 presents the mouse CAI of wild type GluClα1, 
GluClβ, and green fluorescent protein (GFP).  A CAI value of unity would indicate that 
each codon of the gene under analysis is optimal.  The wild type GluClα and GluClβ,  
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FIGURE 4-1 
 
 
 
Figure 4-1. Codon usage of native GluClα1 and β subunits compared with the 
optimized GluClα1 and β subunits synthesized in this study. Percentage frequencies 
of the synonymous codons are shown for each corresponding amino acid.  The most 
prevalent codon is shown in bold. 
 
 
Gene Native CAI Optimized CAI
GFP 0.604 0.950 
GluClα1 0.552 0.953 
GluClβ 0.585 0.951 
 
Table 4-1: Codon Adaptation Index calculations 
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with values of 0.55 and 0.58 respectively, score slightly poorer than the wild-type GFP 
value of 0.6.  Because codon optimization has successfully increased the expression of 
GFP (Haas et al., 1996), we perform analogous modifications to the GluCl genes. 
We chose the one or two most prevalent mouse codons for each amino acid 
(Figure 4-1) to generate a nucleotide sequence for both GluClα1 and GluClβ.  We 
analyzed the resulting nucleotide sequence with a splice site prediction tool from the 
Berkley Drosophila Genome Project (Reese et al., 1997), which revealed several potential 
donor or acceptor sites.  We iteratively modified the nucleotide sequence to eliminate 
these sites.  Additionally, we removed and added a number of restriction sites for 
convenience in cloning.  The final optimized cDNAs for the GluClα1 and GluClβ genes 
contain 399 and 352 silent mutations, respectively, leaving the amino-acid sequences 
identical to the wild type genes.  The new sequences are provided in GenBank, accession 
number AY195802 for the optimized GluClα1 gene, which we call optGluClα1, and 
accession number AY195803 for the optimized GluClβ gene, which we call optGluClβ.   
Figure 4-1 presents the codon usage of the GluCl genes in their native form as well as 
after our optimization procedure.  Codon optimization yielded a significant increase in 
the calculated CAI, as shown in Table 4-, which present comparative data for GFP/EGFP.  
All three genes have a CAI of roughly 0.6 with their native codon usage, and are nearly 
1.0 after optimization.   
 These sequences were synthesized and tagged with fluorescent proteins in the 
M3-M4 loop.  We found that codon optimization yielded a dramatic increase of the 
fluorescent signal of both GluClα1-EYFP and GluClβ-ECFP.  Figure 4-2 presents 
images of neurons transfected with the wild type and codon optimized versions of the  
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FIGURE 4-2 
 
 
Figure 4-2. Increase in channel expression as revealed by fluorescence microcopy.   
(A,B) Native codon usage GluClα1-EYFP fusion and GluClβ-ECFP fusion. The arrow 
indicates the position of the neuron in each panel. 
(C,D) Optimized codon usage optGluClα1-EYFP fusion and optGluClβ-ECFP fusion.  
These are representative cells. 
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GluClα1 and GluClβ genes.  The increase in fluorescence is profoundly noticeable when 
the transfected cultures are viewed by eye: cells transfected with the wild type genes are 
barely visible, whereas those expressing the optimized genes are bright.  The distribution 
of all four genes seems to be primarily somatic.  There were no difference in localization 
between the wild type and optimized genes; this point has not been pursued 
systematically because a somatic localization is adequate for silencing.  The average 
intensity of 10 cells transfected with each of the wild type and optimized GluClα1 and 
GluClβ genes is shown in Figure 4-3A.  Codon optimization alone has provided nearly a 
nine-fold increase in expression of the GluClα1 gene, and a six-fold increase in the 
expression of the GluClβ gene.  We attempted to achieve further increases in expression 
by replacing the signal peptide sequence and 5’ untranslated region (UTR) of the 
optGluClβ gene with that of a highly expressed mouse receptor, nAhCR α4. The result 
was no further increase in fluorescence intensity (data not shown). 
Cotransfection of separate plasmids in this fashion yielded fluorescence signals 
that are highly correlated.  Figure 4-4 shows the normalized ECFP fluorescence signal 
plotted against the normalized EYFP fluorescence signal for each of the 20 cells 
measured.  In data not shown, we verified that there is no cross talk between the two 
channels.  This satisfying result implies that there is roughly the same amount of each 
protein expressed in an individual cell, eliminating the potential complication that cell 
populations would contain GluCl channels of widely differing subunit compositions 
caused by variable expression of the two genes among cells. 
 We performed whole-cell patch clamping to measure the input conductance of 
neurons transfected with the heteromeric wild type GluCl and the heteromeric optimized  
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FIGURE 4-3 
 
Figure 4-3.  Increase in expression measured by fluorescence microscopy and 
electrophysiology.  
(A) Increase in fluorescence measured by averaging 10 cells of both the native codon 
usage genes and optimized codon usage genes.  
(B) Conductance of neurons in the absence and presence of 5 nM IVM.  Each bar 
represents the average of 10 cells. 
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FIGURE 4-4 
 
Figure 4-4: Correlation of signals in the two fluorescent channels, EYFP and ECFP, 
for neurons that have been cotransfected with both optGluClα1-EYFP and 
optGluClβ-ECFP. 
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GluCl.  Previous data show that an IVM concentration of approximately 5 nM applied to 
a GluCl-expressing neuron activates GluCl channel conductance sufficient to silence 
firing due either to glutamate activation or to current pulses (Slimko et al., 2002); but 
non-expressing neurons are unaffected by this concentration of IVM. The response of 
both the wild type and optimized constructs to this IVM concentration is presented in 
Figure 4-3B.  The optimized GluCl genes lead to ~ three-fold greater IVM-induced 
conductance increase than in experiments with wild-type GluCl.  This ratio is probably an 
underestimate, because only the most brightly fluorescent cells expressing nonoptimized 
subunits are chosen for patch-clamp study; and we believe that the results with 
fluorescence are closer to an unbiased average.   
In a previous study, we were unable to measure accurate dose-response relations 
for IVM, due to variability in the expression levels of the genes.  The higher expression 
level, combined with Nupherin-mediated transfection, enables more systematic study 
(Figure 4-5).  The EC50 of the IVM-induced conductance is 1.3 nM, with a Hill 
coefficient of 1.9. 
Minimization of glutamate responses 
 The native ligand for GluCl is glutamate, and we have been concerned that 
unintended GluCl activation by circulating or synaptically released glutamate may also 
inactivate neurons.  Previously data showed that expression of GluClα1 and a mutated β 
subunit, GluClβY182F, results in a heteromeric channel that retains its IVM response 
with an attenuated glutamate response (Li et al., 2002).  We made the Y182F mutation in 
optGluClβ-ECFP and co-expressed this gene with optGluClα1-EYFP in hippocampal 
cultures.  The conductance increase caused by 5 nM IVM is statistically indistinguishable  
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FIGURE 4-5 
 
 
 
Figure 4-5: Dose-response relation for activation of optGluCl channel by IVM.  EC50 
is 1.2 nM and Hill coefficient is 1.9.  Each point represents the average of the input 
conductance of 10 cells at the given concentration of IVM. 
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from the unmutated channel (Figure 4-6A).  However, the maximal response to a 1 s 
application of 100 μM glutamate is reduced seven-fold by this mutation, similar to 
previous Xenopus oocyte data (Figure 4-6B).  In the glutamate response experiments, 
CsCl was used in the internal pipette solution and endogenous glutamate receptors were 
blocked with 100μM CNQX and untransfected control cells had no response to 
glutamate.   
 
Discussion  
Researchers have used codon optimization to increase the expression of a variety 
of cytosolic proteins.  The accompanying increase in expression ranges from modest, 
such as 1.6-fold for Cre (Shimshek et al., 2002) and 2-fold for rtTA (Wells et al., 1999), 
to dramatic, such as 40 to several hundred fold for both GFP and gp120 (Haas et al., 
1996).  This is the first published example of successful codon optimization to increase 
the expression of a membrane protein in mammalian cells.  It is generally thought that 
membrane-bound proteins are limited in surface expression levels by trafficking, sorting, 
and exporting mechanisms, rather than by translation.  However, we find that codon 
optimization provides a large (six– to nine-fold) enhancement of expression.  There was 
little or no further enhancement when the signal peptide sequence of the optimized 
GluClβ gene was replaced with the signal peptide of the mouse nicotinic α4 receptor.  
The codon optimization procedure may prove useful for other studies in which 
nonmammalian ion channels, transporters, and receptors are expressed in clonal 
mammalian cell cells, e. g., for screening of antiparasitic drugs.   
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FIGURE 4-6 
 
Figure 4-6. Effects of optGluClβ Y182F mutation.  
(A) Input conductance in the presence of 5 nM IVM.  The control bar includes three 
groups of cells: cells that were not transfected and tested in the absence of IVM; cells that 
were not transfected and tested in the presence of 5 nM IVM; and cells transfected with 
optGluα1 and optGluClβ or optGluCl βY182F in the absence of IVM.  There were no 
significant differences among these control groups. 5 nM IVM was applied to three 
groups of cells: cells transfected with optGluClα1 only (α); cells transfected with 
optGluClα1 and optGluClβ (αβ); and cells transfected with optGluClα1 and 
optGluClβY182F (αβY182F).  Note that the mutation has no effect on the IVM 
activation of the channel.  
(B) The response to 100 μM glutamate is severely attenuated with the βY182F mutation. 
100 μM glutamate in the presence of 100 μM CNQX was applied to three groups of cells: 
untransfected controls; cells expressing optGluCl α1 and optGluCl β (αβ); and cells 
transfected with optGluCl α1 and optGluClβY182F (αβY182F). 
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Several laboratories are developing genetic and pharmacological techniques for 
selectively silencing specific sets of neurons in vivo with mice or other animals (White et 
al., 2001; Lechner et al., 2002; Nitabach et al., 2002). Such techniques will presumably 
enable various experiments that may give us further insight into the system level 
functioning of the nervous system.  The optimized, fluorescent GluCl constructs 
described here are activated by IVM concentrations of ~ 1 nM, with little interference 
from endogenous glutamate responses, and with ready verification by fluorescence.  This 
relatively low IVM concentration should help avoid known non-specific IVM effects 
(Krusek and Zemkova, 1994; Krause et al., 1998; Khakh et al., 1999; Shan et al., 2001).  
These GluCl subunits provide a robust system for high-efficiency silencing, and we 
consider that the channels are now appropriate for in vivo use.  We are now turning our 
attention to efficient, specific in vivo expression.  The two general strategies are (1) 
transgenic animals, and (2) local injection of viral vectors.   
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C h a p t e r  5  
Usage of the “GluCl/IVM” method in zebrafish to 
understand the role of retinal ganglion cells 
 
 
I thank Ethan Scott in Herwig Baier’s lab for performing the experiments reported here.  
It has been a pleasure visiting Dr. Baier’s lab at UCSF to learn some of the visual 
behavior assays used in zebrafish.  Text in this chapter is unpublished work.
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Abstract 
 We are developing a method for inducible and reversible cell-specific electrical 
silencing of vertebrate neurons in vivo called the “GluCl/IVM” method.  The method 
employs a highly engineered chloride channel, optGluClα-ECFP and optGluClβ-Y182F-
EYFP, from C. elegans that harbors three classes of modifications: 1) We identified a 
single mutagenesis site that ameliorates response to the native ligand glutamate while 
retaining response to the anthelmintic drug ivermectin, 2) we incorporated fluorophores 
into the two channel subunits to aid in visualization, and 3) we re-engineered the entire 
coding sequences to optimize expression levels in vertebrate systems.  The ath5 promoter 
drives expression in peripheral retinal ganglion cells (RGCs) in zebrafish.  Using ath5, 
we generated transgenic zebrafish that express both optGluClα-ECFP and optGluClβ-
Y182F-EYFP.  Immunohistochemistry shows that the genes are expressed as expected in 
the retinal periphery at 5 days post fertilization.  We performed three visual assays of 
these larvae, assessing behavioral changes of transgenic fish revealed by the presence of 
IVM: 1) visual background adaptation (VBA), 2) the optokinetic response (OKR), and 3) 
the optomotor response (OMR).  Wild-type fish behavior is not modulated by IVM.  
While transgenic fish are normal in these assays when IVM is not present, they are 
completely deficient in VBA and significantly altered in OKR when IVM is present.  
OMR is normal in the presence of IVM.  This finding allows us to conclude that the outer 
periphery of the retina is necessary for both normal VBA and normal OKR, while OMR 
does not require input from these cells.  This is the second demonstration of a cell-
specific selective silencing method driving a behavioral modulation in vertebrates. 
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Introduction 
 Vertebrates exhibit numerous reflex behaviors that are driven by visual stimuli.  
In zebrafish and other teleosts, three prominent behaviors have been described, visual 
background adaptation (VBA), the optokinetic response (OKR), and the optomotor 
response (OMR) (Roeser and Baier, 2003).  The VBA, used by the larvae to adapt its 
coloration to the local background, probably serves as a defensive reflex and the OKR 
and OMR probably serve to compensate for self-motion.  The OKR (Figure 5-1A) 
encompasses smooth eye movements and rapid reset movements, or saccades.  The OMR 
(Figure 5-1B) is a reflexive swimming in the direction of perceived motion.  Fish use the 
OMR to maintain a stable position in a flowing river by responding to the apparent 
movement of visual cues present on the riverbed.  VBA, OMR, and OKR can be reliably 
evoked in the laboratory at early larval stages.  Numerous studies used these behaviors to 
identify mutations disrupting development and function of the visual system (Neuhauss et 
al., 1999; Kay et al., 2001). 
It is not yet known where in the zebrafish brain, downstream of the retina, large –
field motion is processed (Roeser and Baier, 2003).  It is likely that dedicated circuits 
exist for these innate responses, but the neural substrates have not yet been identified.  In 
zebrafish larvae, as early as 4 d post-fertilization (4 dpf), retinal ganglion cells (RGCs) 
project their axons to 10 different visual areas, referred to as “arborization fields” (Burrill 
and Easter, 1994).  The proneural gene atonal-homologue 5 (ath5) is closely associated 
with the activation of retinal neurogenesis in all vertebrates.  The gene encodes a basic 
helix-loop-helix transcription factor expressed in a wave-like pattern that prefigures the 
wave of RGC genesis (Masai et al., 2000).  ath5 expression is first  
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FIGURE 5-1 
 
 
Figure 5-1. Schematic of the two visuomotor behaviors investigated in this study. A, 
During the OKR,  immobilized fish respond with eye movements to a moving stimulus in 
their surroundings. B, During the OMR, fish swim to follow a moving stimulus displayed 
on the bottom of their tank.  The direction of motion is indicated by the arrows.  The 
figure is reproduced from Roeser and Baier, 2003 © (2003) The Society of Neuroscience  
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detected in the ventronasal retina at 25 hours post-fertilization (hpf), spreads from nasal 
to more dorsal and temporal retina over the next few hours, and is present throughout 
most of the neural retina at 36 hr.  By 72 hr, when retinal ganglion cell, inner nuclear, and 
photoreceptor cell layers are distinct, ath5 expression is downregulated in differentiated 
neurons but remains expressed in retinoblasts near the ciliary margin (ie, retina 
periphery).  Retinoblasts that express ath5 during this wave do so just after their final 
mitosis; immediately thereafter they begin to differentiate as RGCs (Yang et al., 2003). In 
the absence of functional ath5, these cells either ectopically re-enter the cell cycle or fail 
to exit the cell cycle (Kay et al., 2001)), causing both a failure of RGC genesis and an 
overall delay in the formation of the first retinal neurons. 
We are developing a selective neuronal silencing strategy based upon glutamate-
gated chloride channel subunits from C. elegans called the “GluCl/IVM” method (Li et 
al., 2002; Slimko et al., 2002; Slimko and Lester, 2003).  In this strategy, this exogenous 
chloride channel is expressed in a tissue specific manner in a target organism.  Upon 
systemic administration of the anthelmintic drug IVM, a potent agonist of GluCl, target 
neurons are electrically silenced due to the induction of a large standing chloride 
conductance, presumably leading to a change in organism behavior.  Using enhancer 
elements from the ath5 gene, which drives GFP expression in subsets of RGCs (Masai et 
al., 2003), in combination with the GluCl genes, we are able to modulate the excitability 
of these subsets of RGCs.  These selective silencing experiments allow us to address the 
question of the involvement of specific RGCs in these three visual behaviors. 
 
Materials and Methods 
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Zebrafish constructs and generation.  First the IRES segment from pIRES2-EGFP 
(Clontech) was cloned into poptGluClβ-Y182F-EYFP (Slimko and Lester, 2003), such 
that the ATG start codon of the IRES and the ATG start codon of optGluClβ were 
coincident.  This resulting IRES-optGluClβ cassette was then excised and cloned 
downstream of optGluClα in poptGluClα-ECFP (Slimko and Lester, 2003), resulting in 
poptGluClα-ECFP-IRES-optGluClβ-Y182F-EYFP.  Approximately 7kb of 5’- and 3’-
genomic fragments containing the untranslated regions of the ath5 gene were inserted 
unstream and downstream of the expression cassette of poptGluClα-ECFP-IRES-
optGluClβ-Y182F-EYFP.  Linearization of the construct and microinjection of one-cell 
stage zebrafish embryos followed standard techniques (Xiao et al., 2005).  
Immunohistochemistry.  Transgenic larvae were fixed in 4% PBS-buffered 
paraformaldehyde (PFA), then cryoprotected in 30% sucrose/0.02% azide/PBS before 
sectioning at 12 μm horizontally on a cryostat. Slides were incubated in blocking solution 
(PBS + 3% normal calf serum, 0.3% Triton X-100) for 30 min, then the GFP primary 
antibody (Molecular Probes) was applied (1:1000) overnight in blocking solution at 4 C. 
The immunohistochemical signal was detected with Alexa dye-conjugated secondary 
antibodies (Molecular Probes). Photographs were prepared with a cooled-CCD camera 
(SPOT-RT, Diagnostic Instruments). 
VBA Assay and analysis. The VBA assay was performed as published previously 
(Neuhauss et al., 1999). 5 dpf clutches of mixed wild-type and transgenic animals were 
used for this experiment.  One day before the experiment, 50 nM IVM was added to the 
tanks of half the clutches, the other half was left untouched.  The larvae were taken from 
their tanks and put into a 25 cm Petri dish on a white background and given 15 min to 
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adapt their coloration.  Afterwards, all dark fish were taken out of the dishes and 
genotyped, and a similar number of light fish were also removed and genotyped. 
OMR Assay and analysis. The OMR assay was performed as published previously 
(Neuhauss et al., 1999).  In short, transgenic fish and wild-type controls were individually 
transferred into 30-cm-long and 1-cm-wide Plexiglas tanks on an upward-facing 
computer monitor (Figure 5-1B).  Fish were placed in the middle of the tank and a 
moving sine-wave grating (wavelength of 200°, temporal frequency of 10 Hz) was 
displayed for 30 sec. Ten fish of a given genotype were run simultaneously and scored as 
a group. 
OKR Assay and analysis. The OKR assay (Figure 5-1A) was performed as published 
previously (Roeser and Baier, 2003).  A liquid crystal display projector (In Focus LP 
550) pointed upward into a white paper drum (50 mm height, 56 mm inner diameter) that 
rested on a transparent glass plate. A wide-angle conversion lens (Kenko VC-050Hi) and 
a close-up lens (King CU + 1) were inserted between the projector and the drum to focus 
the projector light into the drum. A neutral gray filter (Contax ND4) and an iris (12 mm 
diameter) were used to reduce the amount of light and to increase the depth of focus. 
Zebrafish larvae were placed in an inverted lid of a 40 mm Petri dish on top of the glass 
plate and immobilized in 2% methyl cellulose. The dish was shielded from the direct 
beam of the projector by a diffuser.  Stimuli were generated on a laptop computer using 
plug-ins written for the public domain software NIH Image/J. The original image was a 
luminance-modulated spoked wheel, which was transformed into a set of vertical stripes 
by the projection process. Movement of the grating was generated by computer-animated 
rotation of the wheel. Stimulus velocity for the sine-wave gratings was 20°/sec.  
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Results 
Codon usage for zebrafish closely matches the engineered optGluCl subunits 
The original GluCl genes come from the invertebrate C. elegans (Cully et al., 
1994).  In previous work, we have found that the expression level of these genes can be 
increased significantly in mouse neurons by re-engineering the codon sequence to more 
closely match the codons preferred in highly-expressed mouse genes (Slimko and Lester, 
2003).  The codon adaptation index (CAI) quantifies the similarity between the codon 
usage of a specific gene and a species of interest.  Before investing in the generation of 
transgenic zebrafish, we calculated the CAIs for both the native and mouse-codon-
optimized GluCl genes (Table 5-1).  With relatively high CAIs, the mouse-codon-
optimized genes appear to have a good chance of expressing well in zebrafish. 
 
Gene Native CAI Optimized CAI 
GluClα 0.644 0.948 
GluClβ 0.673 0.953 
Table 5-1: Codon Adaptation Index for GluCl and OptGluCl subunits relative to 
zebrafish highly expressed genes. 
 
Ath5-driven GluCl expresses in a subset of Retinal Ganglion Cells (RGCs) 
 Ath5-optGluClα-ECFP-IRES-optGluClβ-Y182F-EYFP larvae 4 days post 
fertilization (dpf) express the optGluCl subunits in the retina periphery (Figure 5-2), 
similar to native ath5 expression (Masai et al., 2000).  As expected for an ion channel, the 
expression appears to be localized to the membrane of the cells.  Unfortunately, our  
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FIGURE 5-2 
 
Figure 5-2: Immunohistochemistry localization of GluCl.  Anti-GFP stain of a line 1 
larvae 4 days post fertilization shows GluCl is strongly expressed in the periphery of the 
retina, near the ciliary margin, with decreasing expression toward the center.  This is a 12 
mm horizontal section, the top of the image is nasal and the bottom is temporal. Scale bar 
is 100 μm.  
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attempts to directly visualize the ECFP and EYFP fluorophores failed, indicating that 
expression is not high. 
The VBA in transgenic fish is eliminated in presence of IVM 
 In clutches of 5-day-old zebrafish larvae from each of the founder lines (larvae 
will be mixed transgenic and wild-type), virtually all respond to a light background by 
adapting to a light coloration (Figure 5-3, row 1), exactly as wild-type larvae do.  
However, when clutches of larvae have been kept in tanks containing 50 nM IVM, in 
four of the five lines a substantial fraction stay darkly colored when put on the light 
background (Figure 5-3, row 2).  Line 4 did not seem to respond in this fashion and must 
not express the optGluCl proteins.  After this assay, the larvae were genotyped, and 
nearly all dark larvae were found to be transgenic (Figure 5-3, row 3), whereas the light 
larvae were found to be wild-type (Figure 5-3, row 4).  This indicates that we have a 
specific behavioral deficit that requires both the larvae to be transgenic and the presence 
of IVM.  Apparently, electrical activity in the periphery of the retina is essential for the 
VBA behavior. 
Interestingly, the proportion of larvae that stayed dark in the +IVM experiment 
was not 50%, indicating that either some transgenic larvae were adapting properly or that 
the inheritance of the transgene was not the expected 50% in offspring of the founders.  
In data not shown, we used F2 larvae to show that 50% fail the VBA assay, indicating 
that the latter explanation is correct and most probably the germline of the founders is 
mosaic.  Because we are able to induce the failure of the VBA task with IVM, we sought 
to asses the degree of their inducible visual impairment using additional behavioral 
assays. 
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FIGURE 5-3 
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Figure 5-3: Results of Visual Background Adaptation (VBA).  For each line, clutches 
from the founder were moved from a dark background to a light background, both in the 
absence and presence of 50 nM IVM.  After 15 min of exposure, light and dark larvae 
were counted.  In the absence of IVM, all larvae behave normally and turn light (row 1).  
In the presence of 50 nM IVM, some larvae stay dark (row 2).  Nearly all of these dark 
larvae are positive for GluCl (row 3), whereas all light larvae tested are wild-type (row 
4). 
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The OMR is transgenic fish is unaltered in the presence of IVM 
 For the OMR analysis, we restricted our experiments to using lines 1, 3 and 5.  F2 
clutches of 5 dpf larvae were first subject to VBA analysis to determine transgenesis.  
Approximately 50% of the larvae stayed dark on a light background when treated with 50 
nM IVM, which we have shown in the previous section to be a reliable indicator of the 
presence of optGluCl.  All of these larvae, including both transgenic and wild-type, were 
then put through the OMR analysis in groups of 10 (Figure 5-4).  For each of the three 
lines, transgenic and wild-type performed similarly for both high-contrast and low-
contrast stimuli.  In data not shown, we verified that transgenic larvae without IVM also 
perform similarly to wild-type.  Apparently, the periphery of the retina is not essential to 
maintain a robust OMR. 
The OKR in transgenic fish is altered in the presence of IVM 
 As a third visual behavior, we measured the OKR of wild-type and transgenic fish 
both with and without IVM (Figure 5-5).  Although a number of parameters characterize 
saccades, including tracking rate, saccade frequency, and saccade amplitude, we chose to 
focus on saccade rate for these experiments.  We investigated both a high-contrast and 
low-contrast stimulus.  For two of the three lines, there is no difference in saccade rate 
between wild-type and transgenic larvae in the presence of IVM.  In the third line, line 1, 
there is an approximately 60% deficit in transgenic fish exposed to IVM, compared to 
their wild-type counterparts.  This reduction in performance occurs for both stimuli 
tested.  While it is unclear why there is a difference between lines 1, 3, and 5, it is well-
known that expression level can vary between transgenic lines and that this is a  
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Figure 5-4 
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Figure 5-4: Results from the optomotor response (OMR). OMR scores for three of the 
transgenic lines show no difference between wild-type and transgenic animals.  Both high 
contrast and low contrast stimuli were tried. For line 1, 3, and 5, n = 13, 13, and 6, 
respectively, where one n represents a tank containing 10 larvae, scored as a group. Bars 
shown are standard error.   
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Figure 5-5: Results for the optokinetic response (OKR). Line 1 shows a clear deficit in 
measured saccades per minutes for transgenic larvae in the presence of 50 nM IVM, and 
no deficit for the other two lines.  In the absence of IVM, all larvae behave normally (not 
shown).  The deficit persists for both high contrast and low contrast stimuli.  For lines 1, 
3, and 5, n=29, 9, and 22, respectively, where each n represents a single larvae.  Bars 
shown are standard error. 
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reasonable hypothesis for the cause.  Future experiments are planned to understand this 
difference of behavior. 
Spontaneous activity is identical between wild-type and transgenic 
 We sought to verify that any deficit we observed was not merely the result of 
some generalized motor problem in the transgenic larvae.  When in a Petri dish, larvae at 
this age generally show movement characterized by small bursts that appear uncorrelated 
to any external stimuli.  Hence, we measured spontaneous movement of both wild-type 
and transgenic larvae in the presence of IVM (Figure 5-6). There is no difference 
between the two groups for each of the three lines tested.  
 
Discussion 
 In this study, we used the GluCl/IVM method to electrically silence the peripheral 
retinal ganglion cells of zebrafish and investigated the impact of this cell-specific 
silencing on three visually mediated behaviors.  We discovered that the ath5 promoter 
leads to expression of the optGluCl transgenes in the expected peripheral RGCs, although 
expression level was not so high as we would have liked.  However, we found that IVM 
can modulate two important visual behaviors in these animals, the VBA task and the 
OKR, while leaving a third visual behavior, the OMR, unchanged.  The VBA behavior is 
completely abolished in transgenics exposed to IVM, leading directly to the conclusion 
that electrical activity in peripheral RGCs is essential for VBA function.  It remains an 
open question as to whether centrally located RGCs are also essential for VBA.  In at 
least one line, saccade rates in the OKR are reduced by as much as 60% in IVM-treated 
transgenics compared to wild-type controls.  This suggests an important role of peripheral 
RGCs in the pacing of the saccade-generating mechanism. 
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Figure 5-6: Spontaneous swimming activity.  Wild-type and transgenic larvae from 
each of the three lines have equivalent spontaneous swimming activity, as measured by 
the number of movements per unit time.  For lines 1, 3, and 5, n=9, 6, and 6 where each n 
represents 8 larvae scored as a group.  Bars are standard error. 
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At this time, this is only the second publication to link an electrical silencing of 
cell-type specific neurons to a behavioral change in an intact vertebrate animal. 
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C h a p t e r  6  
Attempts to use the “GluCl/IVM” method in mice 
 
 
Text of this chapter is unpublished work.  I would like to thank Walter Lerchner in David 
Anderson’s laboratory for support in doing the in situ hybridizations, 
immunohistochemistry, and in vivo AAV injections reported in this chapter.
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Abstract 
 We have been developing a technique for reversibly silencing specific neuronal 
populations in mouse brain, which we call the GluCl/IVM method.  It relies on 
expression of a ligand-gated chloride channel from C. elegans engineered for optimal 
expression in mammalian neurons.  In previous work we have demonstrated the 
applicability of the method in cultured hippocampal neurons.  We have pursued four 
approaches to in vivo silencing of mouse brain using the GluCl/IVM method: 1) Sindbis 
virus injection into the brain, 2) adeno-associated virus (AAV) injection into the brain, 3) 
a trkA promoter-driven transgenic mouse, and 4) an L7 promoter-driven transgenic 
mouse.  Two of the methods, the Sindbis virus injection and the trkA mouse, were 
abandoned due to minimal expression levels.  Our AAV experiments are incomplete, but 
appear to show a high level of expression, and behavioral experiments are forthcoming.  
With the L7 promoter-driven transgenic, we have demonstrated expression of the GluCl 
channel through in situ hybridization, immunohistochemistry, direct fluorescent 
detection, and acute dissociated electrophysiology.  Our behavioral assay, the rotarod, did 
not show a conclusive modulation in response to ip dosages of IVM, unfortunately.  Low 
levels of expression of the transgenes probably account for this lack of effect. 
 
Introduction 
 
A useful approach to understanding mechanisms underlying information 
processing and integration in neural circuits involves inactivating specific sets of neurons 
in the neural network.  This approach has been used effectively in Drosophila and 
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Caenorhabditis elegans in some cases by reversibly inactivating a subset of neurons 
(Sweeney et al., 1995; Dubnau et al., 2001; McGuire et al., 2001; White et al., 2001; 
Nitabach et al., 2002).  In mammals, selective ablation of particular cell types within the 
network has been achieved through a variety of genetic techniques (Nirenberg and 
Cepko, 1993; Kobayashi et al., 1995; Watanabe et al., 1998; Gogos et al., 2000). This 
technology has clarified mechanisms underlying development, information processing 
and integration, and behaviors, but also often has led to adaptive and compensatory 
changes in the neural function.  The technology that allows reversible suppression of a 
specific neuronal activity in mammals is desired but still is limited (Callaway, 2005; 
Wulff and Wisden, 2005).  In fact, at the time of this writing there has been only one 
publication of a successful application of reversible behavioral modulation due to 
selective silencing of a neuronal population in a mouse (Yamamoto et al., 2003).  
Additionally, there has been one report of in vivo circuit modulation due to selective 
silencing (Yu et al., 2004), although no behavior was reported. 
 Yamamoto and colleagues developed a “genetics-only” approach that relies on the 
tetracycline transactivator system to induce expression of the light chain of tetanus 
neurotoxin (TeNT) in cerebellar granule cells (Yamamoto et al., 2003).  Because the 
tetracycline-controlled reverse activator (rtTA) requires doxycycline (DOX) to induce 
transcription, temporal control is achieved through addition of doxycycline in the 
animal’s diet.  The light chain of tetanus toxin, once expressed in a neuron, 
proteolytically cleaves synaptobrevin (VAMP2), a protein which is required for synaptic 
vesicle exocytosis (Sudhof, 1995).  The genetically manipulated expression of TeNT with 
the rtTA system thus confers inducible and reversible suppression of synaptic 
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transmission in vivo by DOX-dependent cleavage of VAMP2.  The drawback of this 
approach is the time course.  In Yamamoto’s experiments, mice were treated with DOX 
for 13 days before the behavioral effect was seen, and required 21 days after DOX 
treatment to recover the original, untreated, behavior.  There are three rate limiting steps 
in silencing a neuron with this technique: 1) the pharmacokinetics of doxycycline 
penetrating the target tissues, which are behind the blood-brain barrier, 2) the 
transcription and translation rate of TeNT once DOX is present, and 3) the rate at which 
TeNT cleaves VAMP2.  Presumably, transcription and translation is the limiting step.  
There have been a number of other attempts to electrically silence neurons in mammals; 
these are summarized in Chapter 1. 
 Chloride current is a major mechanism of inhibition in the animal brain.  We have 
been developing a technique that uses invertebrate ligand-gated chloride channels (Li et 
al., 2002; Slimko et al., 2002; Slimko and Lester, 2003).  In these experiments, two 
subunits of a C. elegans glutamate-gated chloride channel (GluClα and GluClβ) were 
expressed in mammalian neurons in vitro and, upon exposure to the anthelmintic drug 
ivermectin (IVM), neurons developed a large standing chloride conductance and were 
effectively silenced.  To optimize these genes for in vivo silencing experiments, we have 
1) ameliorated the activation by the endogenous ligand, glutamate (Li et al., 2002), by 
finding a site specific mutation, 2) incorporated fluorophore tags into each of the subunits 
(Slimko and Lester, 2003), and 3) re-engineered the coding sequences to reflect the 
mammalian preferred codons (Slimko and Lester, 2003).  We call these derivatized genes 
optGluClα-ECFP and optGluClβ-Y182F-EFYP.  In contrast to the TeNT technique, this 
approach does not require synthesis of new proteins to effect neuronal silencing.  We 
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hope the pharmacological nature of this technique will result in a significantly faster time 
course of inactivation and activation.    
We have used this engineered GluCl channel to make two different strains of 
transgenic mice.  The first used a promoter for the neurons in the peripheral nervous 
system, trkA, shown to target DRG neurons (Ma et al., 2000).  The second used a 
promoter for neurons in the central nervous system, L7 (sometimes called Pcp2), which 
targets Purkinje cells of the cerebellum (Oberdick et al., 1990).  We have also used both 
Sindbis virus and adeno-associated virus (AAV) to express these genes in adult animals.  
Unfortunately, our results have not been conclusive.  However, they are summarized in 
the remainder of this article, with advice given for future directions. 
 
Materials and Methods 
 
Mouse constructs and generation.  All procedures for animal treatments were performed 
according to the guidelines of the California Institute of Technology.  The pL7-optGluCl 
expression plasmids (Figure 6-1B) coding for optGluClα-ECFP and optGluClβ-Y182F-
EYFP under control of the L7 promoter were generated by inserting the two genes into 
the BamHI site of the L7-pGEM3 plasmid (Oberdick et al., 1990).  Note that there were 
two plasmids generated, one carrying optGluClα-ECFP and the other carrying 
optGluClβ-Y182F-EYFP.  The plasmids were linearized with HindIII and EcoRI, 
purified, and co-injected into fertilized eggs from wild-type C57BL/6 mice.  At four 
weeks of age, mice were tailed and founders were identified by PCR analysis.  Two 
separate rounds of injection resulted in 72 lines, 5 of which were positive for both  
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Figure 6-1 
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Figure 6-1. Constructs used for transgenic mice generation.  A, the trkA promoter 
construct.  B, the L7 promoter construct.  Note that two different plasmids were 
generated for each mouse, an optGluCla-ECFP containing plasmid, and an optGluClb-
Y182F-EFYP containing plasmid.  The constructs were co-injected to generate a mouse 
that would express both genes. 
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transgenes.  All lines were back-crossed to C57BL/6 for one to three generations before 
physiological analysis. 
Similarly, the trkA-optGluCl constructs (Figure 6-1A) were generated using the trkA 
promoter (Ma et al., 2000).  Briefly, the two genes were cloned into the BamHI site of 
pJ21, the plasmids were linearized, purified, and co-injected into fertilized eggs from 
wild-type C57BL/6 mice.  Five transgenic lines also resulted from these injections and 
were used for expression analysis. 
Sindbis vectors, preparation, and injection.  Sindbis vectors were prepared as described 
(Slimko et al., 2002).  Virus was injected into the Rostral Ventral Lateral Medulla 
(RVLM) via a 30G stainless needle attached by polyethylene tubing to a 10-μl Hamilton 
syringe.  0.5 – 1.0 μl of the virus preparation was injected at a rate of ~0.2 μl per minute.  
The needle remained in place for an additional 5 min to facilitate controlled delivery of 
the virus.  48 h post infection mice were culled for fluorescence and behavior analysis.  
AAV vectors, preparation, and injection. pAAV-optGluClα and pAAV-optGluClβ were 
prepared by cloning optGluClα-ECFP and optGluClβ-Y182F-EYFP between the KpnI 
and NotI sites of pAAV-MCS (Stratagene, La Jolla, CA).  Virus was prepared by 
ViraPur, LLC, San Diego, and supplied as two solutions tittered at 1012/ml.  These 
solutions were mixed at a 1:1 ratio and 0.5 ul was injected into either the amygdala or 
hippocampus, as described above.  48-96 h post infection, mice were culled for 
fluorescence analysis. 
Electrophysiology.  Acute dissociated Purkinje cell preparations were prepared as 
described previously (Raman and Bean, 1999).  Transgenic and C57B/6 mice (postnatal 
day 14-20) were anesthetized with methoxyflurane before decapitation, and the vermal 
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layer of the cerebellum was removed and minced in ice-cold, oxygenated dissociation 
solution containing (in mM): 82 Na2SO4, 30 K2SO4, 5 MgCl2, 10 HEPES, 10 glucose, and 
0.001% phenol red (buffered to pH 7.4 with NaOH). The tissue was then incubated for 
7 min in 10 ml of dissociation solution containing 3 mg/ml protease XXIII (Sigma, St. 
Louis, MO), pH 7.4 with NaOH, at 37°C, with oxygen blown over the surface of the 
fluid. The tissue was then washed in warmed, oxygenated dissociation solution containing 
1 mg/ml bovine serum albumin and 1 mg/ml trypsin inhibitor, and then maintained in 
Tyrode's solution containing (in mM): 150 NaCl, 4 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 
10 glucose, pH 7.4 with NaOH, at room temperature, with O2 blown over the surface of 
the fluid. Tissue was withdrawn as needed and triturated with a fire-polished Pasteur 
pipette to liberate individual neurons. Purkinje cells were identified by their large 
diameter and characteristic pear shape attributable to the stump of the apical dendrite. 
Cells were used between 30 min and 5 hr of trituration. For recording, the bath solution 
was (in mM): 110 NaCl, 5.4 KCl, 1.8 CaCl2, 0.8 MgCl2, 10 HEPES and 10 D-glucose, 
pH 7.4, osmolarity 230 mOsm. Patch pipettes were filled with a solution containing (in 
mM): 100 K gluconate, 0.1 CaCl2, 1.1 EGTA, 5 MgCl2, 10 HEPES, 3 ATP, 3 
phosphocreatine and 0.3 GTP, pH 7.2, 215 mOsm. Holding potential was −60 mV. Input 
conductance was measured by a 5 mV hyperpolarizing pulse. 
In situ hybridization. Nonradioactive in situ hybridization to frozen sections of mouse 
cerebellum was done as previously described (Zirlinger et al., 2001). Templates for 
probes were synthesized by PCR using specific primers for optGluClα-ECFP and 
optGluClβ-Y182F-EYFP and their respective cDNA plasmids.  Briefly, fresh frozen, 20 
μm thick coronal sections were cut with a cryostat.  Sections were dried and fixed in 4% 
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paraformaldehyde, washed in PBS and subjected to acetylation using 0.25 % acetic 
anhydride in 1M triethanolamine-HCl pH 8.0.  Slides were prehybridized for 1–3 hr, and 
hybridized overnight at 68°C, using a probe concentration of 0.5–1 µg/ml.  Sections were 
washed twice in 0.2X SSC at 68°C for 30 min., incubated with anti-digoxigenin alkaline 
phosphatase-conjugated Fab fragments (Roche) at a 1: 2000 dilution in 0.1M maleic acid 
buffer, pH 7.5, with 0.2% Tween-20, 20% sheep serum and 2% blocking reagent 
(Roche). Staining was developed for 4–16 hours with NBT and BCIP (Roche) in alkaline 
phosphatase buffer to yield a purple product.  Slides were fixed in 4% formaldehyde and 
mounted with glycerol.  
Immunohistochemistry.  The primary antibodies used were rabbit polyclonal anti-EGFP 
or anti-calbindin, from Molecular Probes (Eugene, OR).  Briefly, fresh frozen, 20 μm 
thick coronal sections were cut with a cryostat. Sections were fixed in 4% PFA for 10 
min, washed 4x in PBS with 0.1% Triton X100, and then blocked for 20 minutes in 
PBST supplemented with 10% goat serum.  Sections were stained overnight at 4 C with a 
1:1000 dilution of the primary antibody, then washed and blocked as above.  The 
secondary antibody (either Alexa 488 or Alexa 568 from Molecular Probes) was then 
applied to the section as a 1:250 dilution for 2 h at room temperature.  Finally, sections 
were washed 2x in PBS and mounted in 70% glycerol. 
Rotarod behavior tests. The rotarod consisted of a grooved plastic roller (4 cm in 
diameter).  A mouse was placed on the rotarod rotating at 30 rpm.  For the static rotarod 
assay, mice (wild-type and transgenic) were subject to six sessions of three trials per 
session; two sessions were conducted per day.  Each trial lasted until the mouse fell off or 
a maximum 180 seconds. At the end of six sessions, all mice could do the task without 
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failure.  On the next day, mice were injected ip with varying dosages of IVM (5 – 20 
mg/kg), and at various time points after, their performance on the rotarod was measured.  
For the learning rotarod assay, mice (wild-type and transgenic) were injected with 20 
mg/kg IVM 24 hr before the training protocol, and their performance during the six 
training sessions was measured. 
 
Results 
 
Both Sindbis and AAV lead to in vivo neuronal expression 
 Initial viral injection experiments were performed using the Sindbis virus which 
has been described previously (Slimko et al., 2002). Our target area was the rostral 
ventral lateral medulla (RVLM).  Untilateral inactivation of this region with muscimol 
leads to a profound apnea (Gatti et al., 1987), and we chose this as an appropriate simple 
behavioral assay.  To verify the previous reports, we injected 0.5 μl of 100 μM muscimol 
into the left RVLM.  Within 5 min, 3 of 3 mice completely stopped breathing.   Buoyed 
by this result, we injected 3 mice with 1 μl of the Sindbis virus solution that has been 
described (Slimko et al., 2002).  This Sindbis virus has three cistrons to drive expression 
of GluClα, GluClβ, and green fluorescent protein (GFP). Forty-eight hours post injection 
animals were injected ip with 20 mg/kg of IVM.   Animals were observed visually up to 3 
h for signs of abnormal breathing; no lack or change in breathing was observed.  48 h 
after IVM administration, mice were culled; brains were removed, sectioned, and 
mounted so that we could attempt to estimate the expression level by searching for GFP 
fluorescence.  We found that roughly 25% of neurons throughout the RVLM expressed 
GFP (Figure 6-2), which we felt was a reasonable level of infection.  However, 
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Figure 6-2 
 
Figure 6-2: RVLM  sections. A, Nissl staining. B, GFP fluorescence.  C, Merged images.  
All  scale bars shown are 50 mM.  Note that the virus infects only ~25% of the neurons. 
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while doing these experiments, we learned that only a small percentage of cells 
expressing GFP express both subunits of GluCl (Slimko et al., 2002), which led us to 
believe that a very small number of neurons in the RVLM were actually being silenced.  
Hence, we were not surprised that we saw no behavioral phenotype.  At this time, we 
abandoned these experiments. 
 We generated a recombinant adeno-associated virus type 2 (AAV2) as explained 
in Methods, using the engineered GluCl channel subunits, optGluClα-ECFP and 
optGluClβ-Y182F-EFYP.  AAV has been used recently for gene expression experiments 
in the central nervous system (Davidson et al., 2000; Rabinowitz et al., 2002; Rabinowitz 
et al., 2004).  Our target has been the hippocampus, where lesion studies produce 
decrements in contextual fear conditioning (Chen et al., 1996).  We injected 1 μl of a 
virus solution (tittered at 1012/ml) into the hippocampus.  48-96 h after infection, we 
sacrificed the animals and sectioned their brains to assay for expression level (Figure 6-
3).  We used a GFP antibody to enhance the signal from the optGluCl subunits and then 
counterstained with a Nissl antibody (Figure 6-3, A-D).  Infectivity in the target region 
appears to be high, approaching 75%.  Also, we are able to clearly resolve the native 
fluorescence of both subunits (Figure 6-3, E-H).  The fluorescence does indicate, 
however, that there is substantial cell-to-cell variation of expression level.  In 
experiments not shown, we have determined that the bleed-through from any of these 
three fluorophores into the other channels is minimal.  These experiments are currently 
underway and, as of this writing, we have not yet attempted any behavioral experiments. 
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Figure 6-3(A-D) 
  
Figure 6-3(A-D): Infection of the hippocampus with AAV.  A, anti-GFP staining 
showing successful infection of the target region, 20x.  B, Nissl staining of the same 
region, 20x.  C, overlay of A and B.  D, 10x overlay view of hippocampus.  Figure 
continued on next page. 
123 
Figure 6-3(E-H) 
  
Figure 6-3(E-H). E, Native fluorescence of optGluClb-Y182F-EYFP, 60x.  F, Native 
fluorescence of optGluCla-ECFP, 60x.  G, Nissl staining of same view.  H, Overlay of all 
three channels.  
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The trkA promoter does not lead to expression in adult DRGs. 
 The trkA promoter drives expression of lacZ in embryonic dorsal root ganglion 
(DRG) neurons (Ma et al., 2000).  The DRG is involved in the sensation of noxious 
stimuli (Scott, 1992).  Unfortunately, there are no reports concerning the ability of the 
trkA promoter to drive gene expression in adult animals.  However, we generated five 
lines containing the transgenes shown in Figure 6-1.  Despite searching for expression 
with mRNA in situs, fluorescence microscopy, immunohistochemistry, and 
electrophysiology of DRG cultures, we found no evidence of expression in animals from 
P5 to P28.  Because we were trying to develop a mouse with which we could do relevant 
behavioral characterization on adult animals, we decided to abandon this project. 
 
Purkinje cell-specific mice show correct expression 
 
 The L7, or Pcp2, promoter has been used to make several transgenic mouse lines 
with a variety of transgenes (see Table 6-1).  All reports on the use of this promoter 
suggest that it is specific and works with high efficiency.  However, the number of 
“highly-expressing” lines can be as low as 30% of the number of founder lines.  Studies 
of mice with degenerative Purkinje cells (Hilber and Caston, 2001) indicate that mice 
lacking Purkinje cells typically have an ataxic phenotype.  We felt that this type of 
phenotype would constitue a straightforward assay, and hence an L7-driven silencing 
mouse would be a good candidate for the first silencing mouse demonstration. 
 Five different lines of L7 mice were generated in two rounds of pronuclear 
injection using the construct described in Methods.  Transgenesis was determined 
through PCR.  The first round resulted in three lines and the second resulted in two.   F2  
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Table 6-1 
 
Table 6-1. Mouse lines generated using L7 promoter 
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mice were used for subsequent analysis.  To determine the best expressing line with 
which to proceed with behavioral experiments, we performed both in situ mRNA 
hybridization and immunohistochemistry on cerebellar brain slices and looked for the 
lines with the strongest signal.  Figure 6-4 shows the in situ results for two of the 
strongest expressing lines and a negative control.  Both lines have signals for optGluClα-
ECFP and optGluClβ-Y182F-EFYP mRNA above that of wild-type, and the signal is 
restricted to the Purkinje cell layer.  Forebrain sections were also analyzed and found to 
have no signal.  Line 70 has the stronger of the two signals.  Two of the remaining three 
transgenic lines had signals that were barely detectable (data not shown), and the final 
line did not appear to have a positive signal.  
 The optGluClα-ECFP and optGluClβ-Y182F-EFYP genes used to generate these 
mice contain Enhanced Cyan Fluorescent Protein (ECFP) and Enhanced Yellow 
Fluorescent Protein (EYFP), respectively, as fusions (Chapter 3).  This should allow for 
direct detection of the proteins with fluorescence microscopy.  However, before 
proceeding to direct detection, we stained cerebellar sections of lines 70 and 43 with an 
EGFP antibody (Figure 6-5), which detects both EYFP and ECFP.  Clearly, line 70 has 
stronger expression which correlates well with the previous in situ results.  Again, the 
signal was restricted to the Purkinje cell layer and not found anywhere else in the brain. 
 Unfortunately, direct detection of the fluorophores was not straightforward.  
Previous in vitro results had suggested that the channel expressed quite well and was easy 
to detect (Slimko and Lester, 2003).  Detecting the fluorescence in these mice was 
challenging and we spent a significant effort tuning the microscope to acquire a good 
image.  Figure 6-6 presents one of the best high-magnification images that we were able  
127 
Figure 6-4(A-C) 
 
Figure 6-4(A-C): mRNA in-situ hybridizations for wild-type and two lines. A, wild-
type, showing no existence of GluClα or β mRNA. B, the strongest line, line 70, showing 
clear Purkinje expression of α and β mRNAs. C, the next strongest, line 34, showing 
weaker Purkinje cell labeling. 
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Figure 6-4(D-E) 
  
Figure 6-4(D-E): D and E, higher magnification images showing Purkinje cell staining  of 
line 70.  D is optGluCla-ECFP and E is optGluClb-Y182F-EYFP. 
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Figure 6-5 
  
Figure 6-5: Immunohistochemistry of cerebellar slices.  Slices were stained with an 
EGFP antibody, which recognizes both optGluCla-ECP and optGluClb-Y182F-EYFP.  
A, line 70, the strongest expressing line. B, line 43, a weaker line.  Wild-type sections 
had no detectable fluorescence (not shown). C, staining of Purkinje neurons with 
calbindin. D, staining of the same section as B with an EGFP antibody. C and D done 
with line 70. 
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to achieve.  In the ECFP channel, which corresponds to the optGluClα-ECFP protein, we 
saw clear membrane-bound fluorescence in the Purkinje cell layer, although that 
fluorescence was dim.  All slices exhibited significant background fluorescence in the 
EYFP channel, which made detection of the optGluClβ-Y182F-EYFP protein even more 
difficult.  However, as seen in Figure 6-6B, there is membrane labeling of Purkinje cells 
which is not seen in wild-type animals.  This difficulty in detection could be the result of 
either low expression levels or the difficulty of detecting fluorescence in slices.  There 
are a number of reports of detecting fluorescent molecules in cerebellar brain slices of 
transgenic mice (Zhang et al., 2001; Sekirnjak et al., 2003), which favors the former 
explanation. 
Electrophysiology suggests expression is low 
 We performed electrophysiological recordings on acute dissociated Purkinje 
neurons to estimate the expression level of optGluCl.  These types of cultures have been 
shown to retain responses to ligand-gated ion channels such as GABA receptors, 
ameliorating the concern that the preparation technique somehow destroys membrane-
bound proteins (Itier et al., 1996).  The input conductance change in response to 10 nM 
IVM was small, approximately 40% (Figure 6-7).  This is in stark contract to our in vitro 
hippocampal culture results, where input conductance increased by 2000% to 3000% 
(Slimko et al., 2002; Slimko and Lester, 2003).   
  
Rotarod behavior is inconclusive 
 Despite the weak fluorescence signal and the rather small conductance change in 
the acute dissociated Purkinje cell experiments, we proceeded to assay the behavior of 
these animals.  Our assay was the rotarod test, in which mice are placed on a rotating  
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Figure 6-6 
  
Figure 6-6: Direct detection of ECFP and EYFP in L7 line 70. A, image with ECFP 
filter set shows optGluClα-ECFP localized to Purkinje cells.  B, image with EYFP filter 
set shows optGluClβ-Y182F-EYFP also localized to Purkinje cells, although background 
fluorescence was higher.  Both images are grey-scale for clarity.  C, A and B merges 
shows co-localization of the genes.  
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Figure 6-7 
 
Figure 6-7: Acutely dissociated Purkinje cell input conductance.  Cells were held at -
60 mV and the input conductance was measured with 5 mV voltage steps.  Data shown 
are for transgenic animals, 12 cells per group.  Pre is prior to the addition of 10 nM IVM. 
Post is >20 minutes after addition of the drug.  Wild-type animals were studied as well; 
pre and post IVM were statistically indistinguishable (not shown). 
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rod and the amount of time they are able to stay on this rod is measured.  We performed 
two versions of this assay.  The first is a static rotarod performance measurement.  Over 
the course of 3 days we trained both wild-type and transgenic animals to run on a 30 rpm 
rotarod for at least 180 s.  At the end of the three day training period, all wild-type and 
transgenic mice were able to perform the task without failure.  At the beginning of testing 
on day 4, all mice were given an ip dosage of IVM, from 5 to 20 mg/kg.  The rotarod 
performance of each mouse in the wild-type and transgenic groups was measured at 4 
different time points post-injection (Figure 6-8).  There was no significant difference 
between wild-type and transgenic groups for any of the time point/dosage combinations.  
Although the transgenics groups performed poorly at the 20 mg/kg dose and 30 min and 
3 h time points, the wild-type mice performed poorly as well and there is no significant 
difference with the transgenic group.  Very likely the performance decrement at these 
large dosages of 20 mg/kg caused non-specific effects in the animal (see Discussion).   
This was a disappointing result, but correlates with the weak fluorescence and the small 
conductance increase in the presence of IVM reported previously. 
 The second version of the assay was the rotarod learning measurement.  In this 
assay, we administered a single 20 mg/kg of IVM 4 h prior to training the animals on the 
rotarod, and compared the rate at which the wild-type and transgenic animals were able 
to learn the task (Figure 6-9).  There was no significant difference between the learning 
rates of the two groups. 
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Figure 6-8 
 
Figure 6-8. Static rotarod performance.  A, wild-type mice performance on the rotarod 
at various time points after various dosages of IVM.  B, transgenic performance on the 
rotarod under the same conditions.  There is no significant difference between wild-type 
and transgenic. 
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Figure 6-9 
  
Figure 6-9: Learning rotarod paradigm.  Wild-type and transgenic mice (5 each) were 
injected ip with 20 mg/kg of IVM.  4 hr later, they were trained on a 30 rpm for 10 trials, 
over the course of 3 days (during the final day the animal had 4 trials).  There is no 
significant difference between wild-type and transgenic animals.  
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Discussion 
 
 We have shown that transgenic mice made with the optGluCl genes under control 
of the L7 promoter express both mRNA and protein in the correct cell-types.  The in situ 
experiments allowed us to detect mRNAs of both genes; however a limitation of using 
the EGFP antibody is that we cannot distinguish between the two proteins, optGluClα-
ECFP and optGluClβ-Y182F-EYFP.  Given that the fluorescence microscopy as well as 
mRNA in situs indicated that both genes were present, we do not see this as a major 
limitation.  A major concern, however, was that the observed fluorescence of these genes 
was low. 
 We expected to have a much larger electrophysiological signal in response to 
application of IVM.  This technique relies upon activating enough chloride conductance 
to effectively clamp the neuron at or near resting potential, an effect we clearly saw in 
our earlier in vivo experiments.  The change in conductance in the Purkinje neurons was 
~0.4 nS, compared to a ~20 nS change in the previous hippocampal cultures.  Assuming 
that the single-channel conductance and open probability of GluCl is the same when 
expressed in both Purkinje neurons and hippocampal neurons, this implies there is far less 
production of the GluCl proteins in the Purkinje neurons.  This is problematic, for 
Purkinje neurons are typically larger than hippocampal neurons, and they would likely 
require more, not fewer, channels to effectively silence them. 
 Our behavioral experiments indicated no clear modulation in rotarod performance 
to IVM treatment.  One criticism may be that we did not administer enough IVM.  In 
previous experiments, we have determined the dosage of IVM that wild-type mice are 
able to handle without obvious toxic effects (Figure 6-10A).  We found that  
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Figure 6-10: Ivermectin can kill mice.  A, wild-type animals given various dosages of 
IVM. Above 20 mg/kg, IVM becomes lethal.  B, Survival percentages for various 
dosages of IVM, comparing wild-type and mdr1a knockout mouse. The dose which we 
believe should be enough to activate GluCl in a wild-type mouse is shown with the red 
bar.  Panel B adapted from Schinkel et al, 1994. 
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above 20 mg/kg, mice start to have severe ataxia and seizures, followed by death.  
Additionally, we were able to use reported pharmacokinetic data to estimate that an IVM 
dosage of 0.2 mg/kg results in approximately 5 nM IVM in the brain and thus should 
activate GluCl (Schinkel et al., 1994).  This is nearly 100 times less than the dosage we 
used in our behavioral experiments.  We believe we were using enough IVM to activate 
the channel; and any larger dosages of IVM would have severely interfered with 
behavioral tests (in fact, 20 mg/kg seemed to be the beginning of interference in rotarod 
behavior, see Figure 6-8).  Hence, we used the highest possible dosage.  Our most 
probable explanation for the lack of clear behavioral modulation, supported by the weak 
fluorescence signal and the small conductance change of acute dissociated Purkinje 
neurons, is that there simply is not enough GluCl protein to clamp the Purkinje neurons at 
resting membrane potential.  
 Our viral experiments are still under way.  We are encouraged because the 
fluorescence observed after infection appears to be higher than that seen in our transgenic 
animals.  Perhaps these experiments will lead to some behavioral data.  Because of the 
significant behavioral modulation seen in zebrafish (Chapter 5) resulting from use of the 
GluCl/IVM method, we are still hopeful. 
 
References 
Callaway EM (2005) A molecular and genetic arsenal for systems neuroscience. Trends 
Neurosci 28:196-201. 
Chen C, Kim JJ, Thompson RF, Tonegawa S (1996) Hippocampal lesions impair 
contextual fear conditioning in two strains of mice. Behav Neurosci 110:1177-
1180. 
139 
Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, Derksen TA, Zabner J, Ghodsi A, 
Chiorini JA (2000) Recombinant adeno-associated virus type 2, 4, and 5 vectors: 
transduction of variant cell types and regions in the mammalian central nervous 
system. Proc Natl Acad Sci U S A 97:3428-3432. 
Dubnau J, Grady L, Kitamoto T, Tully T (2001) Disruption of neurotransmission in 
Drosophila mushroom body blocks retrieval but not acquisition of memory. 
Nature 411:476-480. 
Gatti PJ, DaSilva AM, Gillis RA (1987) Cardiorespiratory effects produced by injecting 
drugs that affect GABA receptors into nuclei associated with the ventral surface 
of the medulla. Neuropharmacology 26:423-431. 
Gogos JA, Osborne J, Nemes A, Mendelsohn M, Axel R (2000) Genetic ablation and 
restoration of the olfactory topographic map. Cell 103:609-620. 
Hilber P, Caston J (2001) Motor skills and motor learning in Lurcher mutant mice during 
aging. Neuroscience 102:615-623. 
Itier V, Depoortere H, Scatton B, Avenet P (1996) Zolpidem functionally discriminates 
subtypes of native GABAA receptors in acutely dissociated rat striatal and 
cerebellar neurons. Neuropharmacology 35:137-145. 
Kobayashi K, Morita S, Sawada H, Mizuguchi T, Yamada K, Nagatsu I, Fujita K, 
Kreitman RJ, Pastan I, Nagatsu T (1995) Immunotoxin-mediated conditional 
disruption of specific neurons in transgenic mice. Proc Natl Acad Sci U S A 
92:1132-1136. 
Li P, Slimko EM, Lester HA (2002) Selective elimination of glutamate activation and 
introduction of fluorescent proteins into a Caenorhabditis elegans chloride 
channel. FEBS Lett 528:77-82. 
Ma L, Merenmies J, Parada LF (2000) Molecular characterization of the TrkA/NGF 
receptor minimal enhancer reveals regulation by multiple cis elements to drive 
embryonic neuron expression. Development 127:3777-3788. 
McGuire SE, Le PT, Davis RL (2001) The role of Drosophila mushroom body signaling 
in olfactory memory. Science 293:1330-1333. 
Nirenberg S, Cepko C (1993) Targeted ablation of diverse cell classes in the nervous 
system in vivo. J Neurosci 13:3238-3251. 
Nitabach MN, Blau J, Holmes TC (2002) Electrical silencing of Drosophila pacemaker 
neurons stops the free-running circadian clock. Cell 109:485-495. 
Oberdick J, Smeyne RJ, Mann JR, Zackson S, Morgan JI (1990) A promoter that drives 
transgene expression in cerebellar Purkinje and retinal bipolar neurons. Science 
248:223-226. 
140 
Rabinowitz JE, Bowles DE, Faust SM, Ledford JG, Cunningham SE, Samulski RJ (2004) 
Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes 
functionally defines subgroups. J Virol 78:4421-4432. 
Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X, Samulski RJ (2002) Cross-
packaging of a single adeno-associated virus (AAV) type 2 vector genome into 
multiple AAV serotypes enables transduction with broad specificity. J Virol 
76:791-801. 
Raman IM, Bean BP (1999) Ionic currents underlying spontaneous action potentials in 
isolated cerebellar Purkinje neurons. J Neurosci 19:1663-1674. 
Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol 
CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, et al. (1994) 
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the 
blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502. 
Scott S (1992) Sensory Neurons, Diversity, Deevelopment, and Plasticity. Oxford: 
Oxford University Press. 
Sekirnjak C, Vissel B, Bollinger J, Faulstich M, du Lac S (2003) Purkinje cell synapses 
target physiologically unique brainstem neurons. J Neurosci 23:6392-6398. 
Slimko E, McKinney S, Anderson D, Davidson N, Lester HA (2002) Selective electrical 
silencing of mammalian neurons in vitro using invertebrate ligand-gated chloride 
channels. J Neurosci (in press). 
Slimko EM, Lester HA (2003) Codon optimization of Caenorhabditis elegans GluCl ion 
channel genes for mammalian cells dramatically improves expression levels. J 
Neurosci Methods 124:75-81. 
Sudhof TC (1995) The synaptic vesicle cycle: a cascade of protein-protein interactions. 
Nature 375:645-653. 
Sweeney ST, Broadie K, Keane J, Niemann H, O'Kane CJ (1995) Targeted expression of 
tetanus toxin light chain in Drosophila specifically eliminates synaptic 
transmission and causes behavioral defects. Neuron 14:341-351. 
Watanabe D, Inokawa H, Hashimoto K, Suzuki N, Kano M, Shigemoto R, Hirano T, 
Toyama K, Kaneko S, Yokoi M, Moriyoshi K, Suzuki M, Kobayashi K, Nagatsu 
T, Kreitman RJ, Pastan I, Nakanishi S (1998) Ablation of cerebellar Golgi cells 
disrupts synaptic integration involving GABA inhibition and NMDA receptor 
activation in motor coordination. Cell 95:17-27. 
White BH, Osterwalder TP, Yoon KS, Joiner WJ, Whim MD, Kaczmarek LK, 
Keshishian H (2001) Targeted attenuation of electrical activity in Drosophila 
using a genetically modified K(+) channel. Neuron 31:699-711. 
141 
Wulff P, Wisden W (2005) Dissecting neural circuitry by combining genetics and 
pharmacology. Trends Neurosci 28:44-50. 
Yamamoto M, Wada N, Kitabatake Y, Watanabe D, Anzai M, Yokoyama M, Teranishi 
Y, Nakanishi S (2003) Reversible suppression of glutamatergic neurotransmission 
of cerebellar granule cells in vivo by genetically manipulated expression of 
tetanus neurotoxin light chain. J Neurosci 23:6759-6767. 
Yu CR, Power J, Barnea G, O'Donnell S, Brown HE, Osborne J, Axel R, Gogos JA 
(2004) Spontaneous neural activity is required for the establishment and 
maintenance of the olfactory sensory map. Neuron 42:553-566. 
Zhang X, Baader SL, Bian F, Muller W, Oberdick J (2001) High level Purkinje cell 
specific expression of green fluorescent protein in transgenic mice. Histochem 
Cell Biol 115:455-464. 
Zirlinger M, Kreiman G, Anderson DJ (2001) Amygdala-enriched genes identified by 
microarray technology are restricted to specific amygdaloid subnuclei. Proc Natl 
Acad Sci U S A 98:5270-5275. 
 
